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ABSTRACT 
Preclinical models of lupus indicate that T cell-B cell collaboration drives 
antinuclear antibody (ANA) production and sustains T cell activation.  
Autoreactive B lymphocytes are present in the normal repertoire but persist as 
ignorant or anergic cells.  Mechanisms that normally limit T cell activation of 
autoreactive B cells remain incompletely resolved, but potentially include the 
absence of autoreactive effector T cell subsets and/or the presence of autoAg-
specific regulatory T cells (Tregs). Several studies have addressed this issue by 
using experimental systems dependent on transgenic autoreactive B cells, but 
much less is known about the activation of autoreactive B cells present in a 
polyclonal repertoire.  In the second chapter of this thesis, I have explored the 
role of effector T cells and Tregs using mice that express an inducible pseudo-
autoAg expressed on B cells and other antigen presenting cells (APCs). In this 
system, activated Th2 cells, but not naïve T cells, elicit the production of ANAs, 
but ANA production is severely limited by autoAg-specific Tregs.  Bone marrow 
chimera experiments further demonstrated that this B cell activation is 
constrained by radioresistant autoantigen-expressing APCs (rAPC) present in the 
thymus as well as by non-hematopoietic stromal cells located in peripheral 
lymphoid tissue.  Importantly, peripheral rAPC expression of autoAg induced the 
expansion of a highly effective subset of CD62L+CD69+ Tregs. 
The third chapter of this thesis focuses on the contribution of CD8+ T cells 
to fibrosis resulting from sterile lung injury.  Type 2 effector production of IL-13 is 
v
  
a demonstrated requirement in several models of fibrosis, and is routinely 
ascribed to CD4+ Th2 cells.  However, we now demonstrate a major role for 
pulmonary CD8+ T cells, which mediate an exaggerated wound healing response 
and fibrosis through robust differentiation into IL-13-producing pro-fibrotic type 2 
effectors (Tc2).  Remarkably, differentiation of these Tc2 cells in the lung 
requires IL-21. We further show that the combination of IL-4 and IL-21 skews 
naïve CD8+ T cells to produce IL-21, which in turn acts in an autocrine manner to 
support robust IL-13 production.  TGF-β negatively regulates production of IL-13 
by suppressing CD8+ T cell responsiveness to IL-21. Our data illuminate a novel 
pathway involved in the onset and regulation of pulmonary fibrosis, and identify 
Tc2 cells as key mediators of fibrogenesis. 
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 CHAPTER I 
 
Introduction 
Foundations of self/non-self discrimination and immunological tolerance 
The immune system must reliably and continually distinguish between self 
and non-self antigens (Ags) in order to avert autoimmunity and mount 
appropriate responses to pathogens and foreign proteins.  The recognition of 
non-self by immune cells, leads to the pathophysiology of transplant rejection as 
well as appropriate immune responses to potentially harmful foreign Ags.  
Induction of immunological tolerance to self-Ags occurs via complex mechanisms 
in central lymphoid organs (thymus and bone marrow) and peripheral tissues, 
resulting in non-reactivity to self-Ags. 
In vivo evidence of immunological tolerance was first described by Ray 
Owen using studies from bovine twins with in utero vascular anastomoses, which 
he described as “nature’s experiment with parabiosis.”  In these bovine twins, 
each co-twin possessed two antigenically distinct populations of red blood cells 
(RBCs) throughout adulthood.  However, the offspring of a twin sire would not 
inherit both populations of RBCs.  Furthermore, twins with different sires also had 
two blood types, one of which could not have been inherited from either the sire 
or the dame (Owen, 1945).  This evidence suggests that bovine twins exchanged 
RBC precursors in utero that were accepted as “self” by the animal, despite 
being genetically distinct from all other cells.  These studies provided a 
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foundation for Peter Medawar’s remarkable finding that not only monozygotic, but 
dizygotic twins, could accept skin grafts from a co-twin.  Ordinary sibs, however, 
were not tolerant to skin grafts as in the case of dizygotic twins (Anderson et al., 
1951).  The bovine twin studies also provided a partial basis for Fenner and 
Burnet’s theory of immune tolerance—namely that exposure to an Ag early in life 
would lead to tolerance to the same Ag later in life.  This theory provided a 
framework for understanding the active process by which autoimmunity is 
prevented during a lymphocyte’s development and throughout the life of that cell. 
Induction of immunological tolerance requires deletion or functional 
inactivation of self-reactive lymphocytes during development, as well as 
inactivation during scenarios that could lead to activation of mature autoreactive 
lymphocytes in tissues.  Unique surface receptors, which allow for an adaptive 
immune response to a vast number of Ags, are generated during development 
through genetic recombination.  This process routinely results in self-reactive Ag 
receptor expression by T and B lymphocytes.  While most autoreactive 
lymphocytes are deleted before full maturation and emigration from central 
lymphoid organs, between 5-10% of the peripheral blood T or B cell population is 
autoreactive in healthy humans, yet only 3-8% of human suffer from autoimmune 
diseases (Goodnow et al., 1995).  A variety of intrinsic and extrinsic factors are 
responsible for the control of autoreactive lymphocytes after their development 
and will discussed separately for T and B lymphocytes. 
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B cell tolerance 
In the bone marrow, pre-B cells undergo somatic rearrangements to generate 
receptor diversity in a process called V(D)J recombination.  Briefly, the variable 
(V), diversity (D), and joining (J) gene segments are cleaved and recombined 
with the potential to yield billions of unique receptor specificities.  Each B cell 
generally expresses one receptor (although dual-receptor B cells have been 
reported (Li et al., 2002)).  The randomness of V(D)J recombination, while 
generating BCRs that could theoretically aid in protection from any pathogen, 
also leads to the generation of autoreactive BCRs.  In fact, it has been estimated 
that about 75% of early immature B cells and 30% of mature B cells are 
autoreactive in humans (Wardemann et al., 2003).  Strong BCR crosslinking 
upon binding self-Ag leads to elimination (clonal deletion) (Nemazee and Burki, 
1989; Nossal and Pike, 1978) or revision of the BCR (receptor editing) (Radic et 
al., 1993; Tiegs et al., 1993).  Clonal deletion is apoptotic death as the result of a 
self-reactive B cell binding self-Ag in the bone marrow, and is thought to be the 
result of binding to multivalent self-Ag.  Immature B cells are highly susceptible to 
deletion upon self-recognition (King and Monroe, 2000).  Receptor editing can 
occur when the BCR binds self-Ag, triggering upregulation of RAG genes, which 
leads to further rearrangement of Ig light chain genes, thus pairing the heavy 
chain with a new light chain (Goodnow et al., 1995).  However, the processes of 
clonal deletion and receptor editing are incomplete in eliminating autoreactive B 
cells from the B cell repertoire in the bone marrow, and autoreactive cells can 
3
  
exit the bone marrow (Wardemann et al., 2003).  In both humans and mouse 
models, self-recognition by mature B cells can lead to anergy (Goodnow et al., 
1988; Zikherman et al., 2012).  Anergic cells are not stimulated under conditions 
in which a normal mature B lymphocyte would become activated  (for example, 
cognate Ag or anti-IgM) and have a significantly shorter half-life than normal 
mature lymphocytes.  Autoreactive mature B cells in the periphery can also be 
ignorant of self-Ag, meaning that effective activation by self-Ag is unavailable to 
the B cell for reason that include very low concentration of Ag and Ags present 
only in areas from which B cells are normally excluded. 
The foregoing discussion describes B cell tolerance as largely intrinsic.  It 
is important to note here that T cell-B cell interactions can have significant 
influence on the “re-awakening” of an anergic autoreactive B cell (Seo et al., 
2002), but can also eliminate anergic B cells (Rathmell et al., 1995).  
Autoreactive B cells have been most intensively studied in the prototypic 
autoimmune disease systemic lupus erythematosus (SLE), where B cells 
invariably produce (potentially pathogenic) autoantibodies.  However, B cells are 
important effectors in autoimmunity—even in organ-specific diseases where T 
cells are thought to be the major force in disease pathogenesis—through Ag-
presentation, cytokine production, and antibody production (Barr et al., 2012; 
Diana et al., 2013; Falcone et al., 1998; Lyons et al., 1999; Marino et al., 2012; 
Matsushita et al., 2008; Pierson et al., 2014; Silveira et al., 2002).  In chapter II, I 
will describe my results from a model system that studies the result of cognate 
4
  
interactions between T cells specific for a neo-self Ag and naturally occurring 
autoreactive B cells. 
 
T cell development and central tolerance 
The importance of the thymus in immune tolerance was demonstrated by 
experimental neonatal thymectomy in mice, which can result in multiorgan 
autoimmune disease (with predilection gonads and endocrine organs) (Kojima 
and Prehn, 1981; Nishizuka and Sakakura, 1969).  As the T cell receptor (TCR) 
is also generated through somatic rearrangements, autoreactive TCRs are 
expressed by a substantial frequency of developing thymocytes.  CD4+ and CD8+ 
αβ T cells and CD4-CD8- γδ T cells develop in the thymus from bone marrow-
derived lymphoid precursors.  The outer layer of the thymus (cortex) and inner 
region (medulla) contain large numbers of thymocytes (developing T cells).  The 
cortex contains both CD4 and CD8 double-negative (DN) and CD4 and CD8 
double positive (DP) thymocytes.  The medulla contains CD4 or CD8 single-
positive (SP) thymocytes.  Both the cortex and the medulla also contain thymic 
epithelial cells (cTECs and mTECs, respectively) and thymic dendritic cells 
(DCs), which serve an important function in both T cell development and T cell 
tolerance.  Upon migration to the thymus, lymphoid progenitors commit to the T 
cell lineage following interactions with thymic stroma.  In addition to chemokines 
that guide thymocyte migration, cTECs express IL-7 and Notch ligands to support 
T cell development.   In the cortex, DN thymocytes undergo proliferation and 
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TCR gene rearrangements.  At the DN2 stage, thymocytes express CD25 (the 
high-affinity IL-2 receptor; IL-2Rα) and rearrangement of the β chain (or γ and δ 
for progenitors of γδ T cells) begins, which continues and increases during DN3.  
At this stage, a surrogate pre-TCR-α chain is expressed.  Signaling through the 
newly formed pre-TCR halts β-chain rearrangements.  During the DN4 stage, 
thymocytes proliferate extensively.  DP thymocytes re-express RAG genes to 
undergo α-chain rearrangements.  The majority of αβ pairings will result in 
nonproductive TCRs.  Recognition of self-peptide:self-MHC complexes on cTECs 
and DCs promote progression to the SP stage and survival.  The majority of 
thymocytes do not receive a rescue signal as a result of this interaction and die 
by apoptosis, termed death by neglect (Germain, 2002; Rothenberg et al., 2008).   
Strong TCR-self-Ag binding (occurring in about 5% of developing T cells 
(Goodnow et al., 2005)) can lead to clonal deletion of self-reactive T cells in the 
thymus, a mechanism of autoimmunity prevention.  The role of the cortex in 
negative selection has been debated, but can occur (Kisielow et al., 1988).  The 
medulla appears to be the primary site for negative selection.  Cortical SP 
thymocytes migrate to the medulla via CCR7-mediated chemotaxis toward 
ligands expressed by mTECs (Forster et al., 2008; Misslitz et al., 2004; 
Takahama, 2006).  mTECs are crucial for both deletion of thymocytes that have 
high-avidity interactions with self-peptide:MHC complexes, and regulatory T cell 
(Treg) development.  The transcription factor AIRE (autoimmune regulator) is 
expressed by mTECs and controls ectopic, thymic expression of a number of 
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tissue specific Ags (TSA) (Anderson and Su, 2011; Anderson et al., 2002) that 
could become auto-Ags without tolerization of the T cell repertoire.  Deficiency in 
AIRE causes severe autoimmunity in humans and mice, and is due, at least in 
part, to escape of strongly autoreactive T cells from negative selection.  In 
humans, this disease, autoimmune polyendocrine-candidiasis-ectodermal 
dystrophy (APECED), is characterized by damage to cells expressing TSAs 
(such as those expressed in endocrine organs) that are not normally expressed 
in the thymus (Anderson and Su, 2011; Xing and Hogquist, 2012).  To avoid the 
persistence of T cell clones with autoreactivity to TSAs, AIRE-driven expression 
and subsequent negative selection, or diversion of TSA-specific cells into a 
regulatory cell type, is required.  In addition to self-Ag presentation by mTECs, 
DCs are abundant in the medulla relative to the cortex, and can present mTEC-
derived self-Ag (Gallegos and Bevan, 2004) and Ags from the blood on MHC 
(Xing and Hogquist, 2012).   
 
T cell peripheral tolerance 
T cell central tolerance, while effective, is incomplete, and not all Ags that can be 
encountered in the periphery are expressed in the thymus.  Autoreactive T cells 
that are activated by self-Ag in peripheral tissues can be eliminated by deletion or 
anergy, and it is likely that absence of tolerance mechanisms such as these 
could cause autoimmunity.  Several checkpoints exist to ensure that 
appropriately activated T cells survive, and aberrantly activated T cells die.  In 
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addition to TCR ligation, simultaneous costimulatory signaling through CD28 is 
also required, which usually comes from CD80 and CD86 on APCs.  Activation of 
APCs through innate immune receptors by microbial products causes 
uprequation of costimulatory molecules, ensuring that T cells become activated 
under appropriate circumstances.  TCR ligation in the presence of costimulation 
can drive the secretion of paracrine and autocrine growth factors, such as IL-2, 
as well as proliferation and differentiation into effector cells.  Anergy is a possible 
outcome of self-Ag recognition by self-reactive T cell, namely when the T cell 
repertoire is chronically exposed to an Ag (such as a ubiquitous self-Ag) or when 
Ag is presented under sub-immunogenic circumstances, such as the absence of 
costimulation (Josefowicz et al., 2012; Schwartz, 2003; Xing and Hogquist, 
2012).  Activated autoreactive T cells express death receptors such as Fas and 
can be eliminated by fratricidal T cells bearing the appropriate ligand.  This class 
of programmed cell death, termed activation-induced cell death (AICD), can 
occur after TCR ligation (Ju et al., 1995), or after repeated antigen stimulation 
(Kawabe and Ochi, 1991).  Mice that are deficient in Fas or Fas ligand (FasL) 
(mouse strains lpr and gld, respectively, develop severe lymphoproliferative 
disease and systemic autoimmunity (Cohen and Eisenberg, 1991). 
Deletional tolerance to TSAs can occur in peripheral tissues.  As in the 
thymus, TSAs can be ectopically expressed and presented in secondary 
lymphoid organs (SLO) such as the spleen and lymph nodes.  Deaf1 is a 
transcriptional regulator expressed by peripheral lymph node stromal cells 
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(LNSC), and drives transcription of TSAs (Fletcher et al., 2010; Yip et al., 2009), 
which could lead to deletional tolerance.  AIRE is also expressed by APCs in 
peripheral tissue, but mediates transcription of genes that are distinct from AIRE-
dependent genes expressed by mTECs (Gardner et al., 2008).  Chapter II of this 
thesis addresses the role of LNSC in peripheral tolerance by modulation of Treg 
activity. 
 
Treg development and role in peripheral tolerance 
Despite extensive recessive tolerance in developing and mature T cells, 
immunoregulation is required during homeostasis and during appropriate 
immune responses.  Dominant tolerance – the active regulation of immune 
responses by Tregs – is established in the thymus during T cell development and 
reinforces the inhibition of autoreactive or over-exuberant immune responses.  
Conventional Tregs are CD4+ T cells that express both CD25 and the 
transcription factor Foxp3 – the master regulator of Treg function (Fontenot et al., 
2003; Hori et al., 2003).  Deficiency of Foxp3 causes IPEX syndrome (immune 
dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome) in humans 
and mice, a fatal, T cell-driven autoimmune disease.  A prevailing model of Treg 
development proposes a TCR driven (instructive) component as well as 
secondary and tertiary factors such as cytokine signaling and costimulation 
(Josefowicz et al., 2012).  The instructive component of the model posits 
intermediate avidity, rather than low avidity (as is required for positive selection) 
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or high avidity (autoreactive) self-peptide:self-MHC interactions with TCRs drives 
Treg development (Josefowicz et al., 2012; Lee et al., 2012; Xing and Hogquist, 
2012).  In addition to self-specificity, IL-2 signaling through CD25 is required for 
Treg maintenance and optimal Treg development (Fontenot et al., 2005).  The 
role of IL-2 in tolerance was described by deletion of IL-2 or IL-2Rα (CD25), 
which led to severe autoimmunity and T cell deregulation (Sadlack et al., 1995; 
Sadlack et al., 1993; Willerford et al., 1995).  Other common gamma chain 
cytokines such as IL-7 and IL-15 may compensate for loss of IL-2 signaling in 
developing Tregs (all signal through STAT5) (Vang et al., 2008).  Mice with T cell 
specific ablation of STAT5 also exhibit a more severe reduction in Tregs (Burchill 
et al., 2007). 
 TGF-β has an important role in extrathymic Treg development (Bilate and 
Lafaille, 2012), however, the exact role of TGF-β in thymic Treg development is 
less clear.  Mice with T cell lineage-specific deletion of TGF-βRI develop fewer 
Tregs during the first several days after birth; however, an IL-2 dependent 
compensatory increase follows later (Li et al., 2006; Liu et al., 2008).  TGF-βRII-
deficient mice have increased thymocyte death in response to anti-CD3 
injections.  Moreover, mice expressing chicken ovalbumin (ova) in pancreatic 
islets crossed to OT-II (ova-specific transgenic CD4+ T cells) exhibited increased 
negative selection and decreased thymic Tregs in the absence of TGF-βRII.  This 
reduction in thymic Tregs in TGF-βRII deficient mice is due to Bim mediated 
apoptosis (Ouyang et al., 2010).  These data implicate TGF-β signaling as a 
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critical positive regulator of thymic Tregs through promoting survival during 
negative selection.  The transcription factor Smad3 is downstream of TGF-β 
signaling and can bind a Foxp3 enhancer element (Tone et al., 2008).  This 
enhancer element, CNS1, appears to be dispensable for thymic Treg generation, 
but required for peripheral Treg development (Zheng et al., 2010); however, this 
has been disputed (Schlenner et al., 2012). 
In peripheral tissues, CD4+ T cells specific for foreign (such as 
environmental or food Ags) and self-Ags (such as those derived from apoptotic 
debris) can differentiate into Tregs (induced Tregs; iTregs).  For example, 
apoptotic debris uptake by immature (non-activated) APCs can induce 
differentiation of IL-10 producing self-Ag specific Treg (Lutz and Schuler, 2002) 
and local increases in TGF-β that can drive Foxp3 expression (Perruche et al., 
2006).  Higher affinity TCR interactions may also determine Treg versus non-
Treg fate peripherally (Gottschalk et al., 2010), and TCR specificity appears to be 
key, although there is only partial overlap between TCR repertoires of thymic 
Tregs and peripherally induced Tregs (Lathrop et al., 2008).  Treg peripheral 
induction can also occur in response to chronic exposure to Ag (Daniel et al., 
2011; Kretschmer et al., 2005), suggesting that there may be cell-intrinsic 
qualities that dictate the fates of anergy versus iTreg. 
Tregs restrain both appropriate immune responses and immune 
responses against self-Ags.  CD4+CD25+Foxp3+ Tregs suppress immune 
responses using both contact-dependent, and secreted factors (Feuerer et al., 
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2009; Shevach, 2009).  Tregs can modulate local levels of T cell nutrients and 
growth factors to limit effector T cell function.  For example, high levels of CD25 
expression on Tregs leads to high IL-2 consumption, and decreases IL-2 
availability for activated lymphocytes (Gasteiger et al., 2013; Pandiyan et al., 
2007; Sitrin et al., 2013).  CTLA-4 is also crucial for Treg-mediated suppression, 
and Treg-specific CTLA-4 deficiency leads to lymphoproliferation and 
autoimmunity (Wing et al., 2008), and sustained CTLA-4 expression by Tregs 
mediates protection from the autoinflammatory disease that occurs in Ctla4-/- 
mice (Friedline et al., 2009). 
Foxp3 expression has been reported in other regulatory T cell types, 
including CD8+ T cells (Robb et al., 2012; Suzuki et al., 2012) and T follicular 
helper cells (Tfh) (Chung et al., 2011; Linterman et al., 2011; Wollenberg et al., 
2011), but the contribution of these unconventional Foxp3+ cells has not been 
fully elucidated. 
Tregs can respond to the inflammatory milieu generated by Th1, Th2, and 
Th17 cells (described in the following section), modifying Treg trafficking and 
suppression modalities.  Treg-specific deletion of STAT3 leads to uncontrolled 
Th17 responses, which is accompanied by decreased expression of IL-6R, IL-
1βR, and CCR6.  CCR6 promotes Th17 recruitment to sites of inflammation 
(Esplugues et al., 2011; Hirota et al., 2007; Wang et al., 2009), and thus could 
promote Treg recruitment to sites of Th17 inflammation to restrain inflammation.  
Similarly, Th2 development is dependent on IRF4 (Lohoff et al., 2002; 
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Rengarajan et al., 2002), and expression of IRF4 is required to suppress Th2 
responses (Zheng et al., 2009).  However, IRF4 may also important in the 
differentiation of Th17 cells (Brustle et al., 2007).  Transcription factors 
discovered in the context of a particular Th subset can be important for the 
development of more than one type of Th (for example, IRF4 (Brustle et al., 
2007) or STAT3 (Stritesky et al., 2011)).  Thus, the requirement for Treg 
expression of specific transcription factors to suppress specific Th responses is 
likely more complex than programming Tregs to become suppressive 
homologues of Th subsets. 
 
Effector T cell differentiation 
The research chapters of this thesis will present data on preclinical models of 
autoimmune and autoinflammatory diseases that are in part dependent on 
aberrantly activated T and B lymphocytes.  T cells mediate autoimmunity through 
providing help to B cells, secreting cytokines that promote inflammation, and 
causing tissue damage.  Recognition of pathogen-associated molecular patterns 
(PAMPs) or damage-associated molecular patterns (DAMPs) by the innate 
immune system triggers T cell responses that are tailored to different pathogen 
types.  The resulting cytokine milieu is a key factor in determining T cell 
differentiation, which is largely governed by transcription factors downstream of 
cytokine receptors.  T cell subsets have been largely defined by production of a 
few key cytokines at the exclusion of production of other cytokines, however, T 
14
  
cell subsets can exist along a continuum.  As these canonical subsets have quite 
different effector functions in both appropriate immune responses and in 
autoimmunity, a brief discussion of T cell differentiation and function is apropos. 
Th1 and Tc1 cells are CD4+ or CD8+ T cells, respectively, which secrete 
IFN-γ.  T-bet is the master regulator of Th1 differentiation, and IFN-γ is a major 
inducer of T-bet (Lighvani et al., 2001), thus Th1 development is positively 
regulated by IFN-γ.  Required for effective viral clearance, IFN-γ is the “default” 
cytokine secreted after T cell activation.  IL-12 secreted by DCs and 
macrophages during Ag presentation drives Th1 differentiation (Heufler et al., 
1996; Hsieh et al., 1993; Manetti et al., 1993). 
CD4+ T cells that produce IL-17A (Th17) are implicated in several 
autoinflammatory conditions.  Th17 cells can also produce IL-21, a highly 
pleiotropic cytokine, and IL-22, which has important functions in barrier immunity 
(Korn et al., 2009).  A combination of IL-6 (or IL-1β or IL-21) and (low-
concentration) TGF-β promote IL-17A production by T cells in vitro an in vivo and 
expression of RORγT (or human homolog Rorc), a transcription factor that is 
crucial for Th17 differentiation (Ivanov et al., 2006; Korn et al., 2009).  IL-23, 
produced by macrophages and DCs supports Th17 differentiation and effector 
cytokine production (Korn et al., 2009; Langrish et al., 2005).  IRF4, BATF, and 
STAT3 are also important regulators of Th17 differentiation (Littman and 
Rudensky, 2010).  A subset of CD8+ T cells also produces IL-17A (Tc17), and 
can be differentiated in vitro under Th17-skewing conditions (Hamada et al., 
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2009; Yen et al., 2009).  In vivo, Tc17 cells and are protective following 
vaccination (Nanjappa et al., 2012) and viral infection (Hamada et al., 2009; Yeh 
et al., 2010). 
Th2 cells provide protection from helminth infection, are elicited by 
allergens and cause symptoms of allergy, and are involved in both normal and 
pathological tissue repair (fibrosis).  Th2 cells are at the helm of type 2 
responses, defined by production of IL-4, IL-5, and IL-13 and recruitment of 
basophils, eosinophils, and mast cells (Oliphant et al., 2011).  IL-4 drives Th2 
differentiation (Swain et al., 1990), and IL-2 is also important (Ben-Sasson et al., 
1990; Le Gros et al., 1990).   Th2 responses can also be initiated by the release 
of innate-derived factors such as thymic stromal lymphopoieitin (TSLP) (Paul, 
2010), IL-25 and IL-33 (Oliphant et al., 2011), the latter of which can be released 
by damaged cells (Moussion et al., 2008).  Type 2 responses drive normal tissue 
repair, as well as unchecked operation of wound healing pathways (fibrosis) 
(Wynn, 2004). 
 
Th2/Tc2 cells and fibrosis 
Repair processes that are activated by wounding attempt to restore normal tissue 
architecture.  An initial inflammatory response consisting of innate immune cells 
(mostly neutrophils, monocytes, and macrophages) serves to respond to 
potential pathogens and close the wound to prevent infection.   T cells make up a 
large percentage of leukocytes at sites of repair during the tissue-remodeling 
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phase.  The extent and type of inflammation impacts the quality of damage repair 
(Eming et al., 2007).  Th1 cells antagonize wound repair pathways (Ishida et al., 
2004), in part by negatively regulating fibroblast activation, which is required for 
production of collagen and tissue repair (Wynn, 2004).  Th2 cytokines promote 
fibroblast activation and the differentiation of pro-repair M2 macrophages (Wick 
et al., 2013).  After injury, macrophages secrete copious TGF-β in response to IL-
13 (Lee et al., 2001; Wynn, 2004).  Activation of fibroblasts by TGF-β and 
consequent collagen production is crucial for both wound healing and fibrosis 
(Wynn and Ramalingam, 2012).  Sustained activity of activated fibroblasts results 
in fibrosis, a deleterious accumulation of collagen and extracellular matrix 
components that causes organ dysfunction. 
Fibrosis is a frequent result of chronic inflammatory conditions, and 
despite the prevalence of fibrosis as both a primary disease and a consequence 
of common diseases such as asthma and heart failure, treatments that 
specifically target fibrogenesis are extremely limited (Wynn and Ramalingam, 
2012).  Idiopathic pulmonary fibrosis is a chronic debilitating for of lung fibrosis 
with a high rate of mortality (King Jr et al., 2014).  Interstitial lung disease in 
systemic sclerosis (SSc) is a chronic, progressive fibrosis that is the leading 
cause of mortality in patients with diffuse disease (Wells et al., 2009).  Th2 
cytokines such as IL-4 and IL-13 are pro-fibrotic promoting and are elevated in 
IPF (Murray et al., 2013) and SSc (Hasegawa et al., 1997).  Nevertheless, the 
actual role of activated Tc2 cells relative to Th2 cells and the genesis of Tc2 cells 
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in vivo is poorly understood, despite evidence that both Tc2 and Th2 persist in 
patients with fibrosis (Atamas et al., 1999; Fuschiotti et al., 2013; Fuschiotti et al., 
2009).  Chapter III focuses on a fibrotic response due to sterile tissue injury, and 
specifically addresses the role of IL-21 in regulating over-exuberant type 2 
responses. 
 
IL-21 can regulate T cell differentiation and function 
IL-21 is a relatively newly identified common γ-chain cytokine produced mainly by 
activated CD4+ T cells, although it may be produced by NKT cells, γδ T cells, and 
CD8+ T cells.  IL-21 secreted by CD4+ T cells promotes CD8+ T cell-mediated 
control of chronic viral infection (Frohlich et al., 2009; Yi et al., 2009), which 
implicated IL-21 as a form of CD4 help to CD8 cells.  IL-21 can promote survival 
of naïve T cells, and in conjunction with other common γ-chain cytokines (IL-7, 
IL-15), promotes T cell proliferation (Zeng et al., 2005).  IL-21 was previously 
thought to be a Th2 specific cytokine (Frohlich et al., 2007; Wurster et al., 2002), 
but more recent data show that IL-21 can be produced by several T cell subsets 
and can act in and autocrine and paracrine manner (Eto et al., 2011; Korn et al., 
2007).  The IL-21 receptor is a homodimer consisting or the IL-21R subunit and 
the common cytokine receptor γ-chain.  As with all common γ-chain cytokines, 
IL-21R binding activates Janus kinases JAK1 and JAK3.  The main signal 
transducer and activator (STAT) that IL-21 activates is STAT3, but can also 
signal through STAT1, STAT5a, and STAT5b (Rochman et al., 2009). 
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In addition to the role of IL-21 in promoting T cell responses (Elsaesser et 
al., 2009; Kasaian et al., 2002; Spolski and Leonard, 2008; Yi et al., 2009), IL-21 
is important in both germinal center (Eto et al., 2011; Zotos et al., 2010) and 
extrafollicular (Lee et al., 2011; Odegard et al., 2008) responses in the 
generation of antibody (Ozaki et al., 2002).  IL-21 is associated with inflammation 
and autoimmunity, and has pathogenic roles in murine models of type 1 diabetes 
(Ramanathan et al., 2011; Spolski et al., 2008; Sutherland et al., 2009) and SLE 
(Bubier et al., 2009; Herber et al., 2007; McPhee et al., 2013; Yang et al., 2013). 
 
T and B cells in SLE 
SLE is a progressive, multisystem autoimmune disorder characterized by 
sustained activation of the innate and adaptive immune systems leading to end-
organ damage.  Progressive renal disease is a common cause of morbidity and 
mortality.  SLE patients invariably test positive for anti-nuclear antibodies (ANAs), 
which are common among autoimmune diseases (Marshak-Rothstein, 2006; 
Rahman and Isenberg, 2008).  Disruption of autoantibody (autoAb) production is 
a promising therapeutic target since the kidney manifestation of SLE, 
glomerulonephritis, is caused in large part by deposition of immune complexes 
containing autoAbs and their cognate antigens.  The majority of autoAbs 
generated by SLE patients are specific for macromolecular complexes containing 
nucleic acids or are specific for nucleic acids themselves (Marshak-Rothstein, 
2006).  TLR7, which binds single-stranded RNA, and TLR9, which binds DNA, 
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are required for production of RNA-associated autoAb and DNA associated 
autoAb, respectively, in murine models of lupus (Christensen et al., 2006). B cells 
and plasmacytoid dendritic cells can become activated by DNA or RNA-
associated protein autoAgs containing endogenous TLR7 and TLR9 ligands, thus 
further perpetuating T and B cell responses to those targets (Marshak-Rothstein, 
2006). 
 The pathogenic potential for B cells in SLE is not limited to autoantibody 
production.  Following activation, B cells can also produce cytokines that may 
drive inflammation (Lund, 2008; Wojciechowski et al., 2009) and can present 
autoAg to T cells (Chan and Shlomchik, 1998; Mamula et al., 1994).  B cell 
deficiency significantly reduced the number of spontaneously activated T cells a 
murine model of lupus (Chan and Shlomchik, 1998) and also reduced T cell 
infiltration into the kidneys independently of antibody secretion (Chan et al., 
1999). These studies suggest that B cells may propagate SLE through serving as 
APCs to autoreactive T cells.  These studies implicate a chronic positive 
feedback loop resulting from interactions between autoreactive T and B cells, 
which is likely to promote SLE.  In chapter II, I examine the activation of 
endogenous autoreactive B cells by activated T cells, and the tolerance 
checkpoints that limit autoAb production. 
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CHAPTER II 
A specific role for secondary lymphoid organ stroma in the activation and 
elaboration regulatory T cells to suppress autoantibody production 
 
Introduction 
Systemic lupus erythematosus (SLE) is a progressive, multisystem autoimmune 
disease characterized by anti-nuclear autoantibody (ANA) production by 
aberrantly activated autoreactive B cells, immune complex deposition in the 
kidneys, joints, vasculature and skin, elevated inflammatory cytokine levels in the 
serum, and persistent autoreactive T cell activity.  T and B cells are thought to 
have a cooperative relationship in SLE, as B cell deficiency significantly reduces 
the number of T cells exhibiting an activated/memory phenotype and subsequent 
T cell infiltration of the kidneys in autoimmune prone mice (Chan and Shlomchik, 
1998; Chan et al., 1999; Shlomchik et al., 1994).  Moreover B cell depletion 
therapy, including the use of rituximab (an anti-CD20 antibody) can lead to the 
loss of activated T cells in lupus patients and decreased ANA titers (Furtado and 
Isenberg, 2013; Sfikakis et al., 2005).  Consequently, the biology of autoreactive 
B cells is an area of active investigation.   
Autoreactive B cells with a hyporesponsive phenotype and a decreased 
half-life (anergy) or that are ignorant of cognate self-Ag exist in healthy humans 
and mice.  Although anergic autoreactive B cells are functionally inactivated, they 
could theoretically be activated when provided with T cell help.  Several studies 
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have addressed this issue using transgenic B cells.  Anti-hen egg lysozyme 
(HEL) B cells can be activated by soluble self-Ag and T cell help.  HEL B cells 
are rendered anergic in mice that also express soluble HEL and are not activated 
by soluble Ag even in the presence of T cell help (Cooke et al., 1994).  
Conversely, anti-DNA B cells (3H9) are also anergic, but can be re-activated by 
provision of cognate interactions with T cells (Seo et al., 2002).  Prior studies 
also point to a role for autoreactive T cells in the activation of ignorant B cells 
(Sweet et al., 2011).  These results indicate that the nature of self-Ag and the 
level of BCR crosslinking influence the activation of autoreactive B cells in 
response to T cell help, and as such, this question warrants study of endogenous 
autoreactive B cells. 
The contribution of effector T cells to autoreactive B cell antibody 
secretion and accumulation has been studied in vivo by depletion of CD4+ T cells 
in autoimmune prone mice (Santoro et al., 1988; Wofsy, 1986; Wofsy and 
Seaman, 1985, 1987) and genetic deficiency of key T cell cytokines such as IL-4 
and IFN-γ (Nakajima et al., 1997; Peng et al., 1997).  In most murine models, 
Th1 cells, which produce IFN-γ and IL-2, have been identified as pathogenic 
(Peng et al., 2002), and a Th1 signature has been identified in SLE patients 
(Theofilopoulos et al., 2001).  Th2 cells, are effective B-helper cells at least in 
part through production of IL-4 and have been largely understudied in the context 
of lupus despite the fact that IgE autoantibodies—a Th2-dependent isotype—are 
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increased in patients with active SLE (Charles et al., 2010).  Thus, the 
contribution on Th2 cells to SLE warrants further investigation. 
 Activation of both antigen presenting cells (APCs) and autoreactive 
lymphocytes can be restrained by regulatory T cells (Tregs).  While many 
autoimmune diseases appear to be multifactorial, in light of recent evidence of 
Treg insufficiency, deregulation, and dysfunction in autoimmunity (Buckner, 
2010; Long and Buckner, 2011; Yan et al., 2008), determining the role of antigen 
(Ag)-specific Tregs in engaging self-Ag presenting, autoreactive B cells and 
tuning their function becomes clinically relevant. Treg Ag-specificity may not be 
crucial, since several studies have demonstrated that Ag-specific Tregs can 
prevent the activation of neighboring T cells with different specificities (Tarbell et 
al., 2004; Thornton and Shevach, 1998).  At least two studies have highlighted 
the requirement for Ag-specific interactions between Tregs and autoreactive B 
cells for effective suppression of autoantibody production in the context of 
immunization against tissue-associated Ags (Gotot et al., 2012; Ludwig-Portugall 
et al., 2009). 
 Treg development in the thymus depends in part on non-hematopoietically 
derived radioresistant cells in the thymus, namely medullary and cortical thymic 
epithelial cells (mTECs and cTECs). mTECs present self-peptide:MHC-II 
complexes directly, and mTEC-derived self-Ag is presented by neighboring 
dendritic cells (DCs) (Gallegos and Bevan, 2004; Roman et al., 2010).  As in the 
thymus, non-hematopoietic APCs in secondary lymphoid organs (SLO) can 
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express transcription factors such as AIRE and Deaf1, which drive ectopic 
expression of tissue specific Ags.  These lymph node stromal cells (LNSC) have 
an important role in the prevention of autoimmunity by both constitutively 
expressing and presenting tissue specific Ags and decreasing T cell proliferation.  
Specifically, LNSC mediate CD8+ T cell tolerance through the deletion of 
autoreactive CD8+ T cells and iNOS-dependent suppression of proliferation 
(Fletcher et al., 2010; Fletcher et al., 2011; Khan et al., 2011; Lukacs-Kornek et 
al., 2011; Siegert et al., 2011).  The role of LNSC in regulating CD4+ T cell 
tolerance—especially in relation to Tregs—is less clear, however, LNSC do 
constitutively express low levels of MHC-II and upregulate MHC-II in response to 
inflammatory stimuli (Malhotra et al., 2012). 
 We have developed a model to study cognate interactions between 
autoreactive T cells and self-Ag presenting B cells in the presence or absence of 
Ag-specific Tregs.  In this chapter, I show that T cell activation is an important 
checkpoint in the prevention of autoantibody production, autoreactive T cell 
activation is sufficient for autoantibody production by autoreactive B cells, and 
that stromal self-Ag presentation is required to most effectively control 
autoantibody responses. 
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Results 
Development of a transgenic mouse expressing an inducible autoAg. 
In order to study autoreactive B cell responses to cognate help from activated 
autoreactive T cells, double transgenic mice were generated to express an 
inducible, systemic pseudo-autoAg.  The TGO fusion construct was developed to 
encode the transmembrane domain of transferrin (to target protein expression to 
the cell surface), green fluorescent protein (for identifying expression of the 
construct), and chicken ovalbumin (the selected “pseudo-autoAg” that elicits T 
cell activation)(Saff et al., 2004).  This construct was cloned into a tetracycline-
responsive element (TRE)-containing plasmid and used to generate the TRE-
TGO mouse.  The reverse tetracycline transactivator (rtTA) activates expression 
of TGO in response to tetracycline or the synthetic derivative doxycycline (dox) 
(Rosenblum et al., 2011), although expression levels are sufficiently low to 
preclude detection of GFP.  When TRE-TGO is crossed to the Ii-rtTA transgenic 
line, expression of OVA in MHC class II+ cells can be induced by dox (Figure 
2.1A).  This cross, referred to as Ii-TGO, enables TGO to serve as a pseudo-
autoAg where OVA is expressed by all MHC-II+ cells and is continually presented 
to autoreactive CD4+ T cells for as long as the mice are maintained on dox.  To 
confirm the inducible expression of the TGO construct and effective presentation 
on MHC-II, we adoptively transferred naïve CFSE-labeled OVA-specific DO11.10 
(DO11) CD4+ T cells into Ii-TGO mice in the presence or absence of dox.  DO11 
cells divide in Ii-TGO mice only in the presence of dox (Figure 2.1B), 
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Figure 2.1. Naive autoreactive T cells proliferate robustly in response to 
self-Ag. 
 
(A) Schematic of the TRE-TGO construct and breeding strategy for generating Ii-
TGO mice. 
(B) 5x106 magnetically purified splenic CD4+ T cells from naïve DO11 mice were 
CFSE labeled and then adoptively transferred into Ii-TGO mice consuming 
normal chow or dox chow.  At day 5 post-injection, spleens were harvested from 
mice and analyzed by flow cytometry. 
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demonstrating that TGO expression and presentation by APCs is sufficient to 
induce Ag-specific T cell division and is tightly controlled by dox administration. 
 
Ii-TGO mice develop lupus-like autoimmune disease following adoptive 
transfer of activated DO11.10 T cells. 
Chronic amplification loops due to sustained T cell-B cell interaction are thought 
to promote systemic autoimmunity in B cell driven diseases such as lupus.  For 
autoreactive B cells activated by autoAg complexes that incorporate TLR ligands, 
unprimed T cells have clearly been shown to enhance the extent of autoantibody 
production and isotype switching of transgenic B cells (Seo et al., 2002; Sweet et 
al., 2011). We sought to determine whether autoreactive T cells specific for a 
systemically expressed neo-self-Ag could elicit autoantibody production from a 
naïve normal B cell repertoire.  To address this question, we first adoptively 
transferred either naïve DO11 cells or in vitro activated Th2 DO11 T cells into Ii-
TGO mice fed normal or doxycycline chow.  Over a period of up to 12 weeks, 
neither the naïve DO11 or activated T cells induced ANA production, suggesting 
that cognate interactions between naïve T cells and unprimed autoreactive B 
cells was not sufficient for autoantibody production.  Previous work from our lab 
has shown that activated but not unprimed B cells express detectable levels on 
TGO mRNA in the presence of dox.  To determine whether naive DO11 T cells 
could engage Ii-TGO B cells in vivo, we purified Ii-TGO B cells and pulsed them 
with ova peptide (pOVA), dox, or PBS (diluent) in vitro.  We then adoptively 
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transferred CD4+ T cells purified from DO11 Rag2-/- mice and Ii-TGO B cells into 
Rag2-/- mice on normal or dox chow.  Splenocytes from these mice were 
analyzed after 5 days by flow cytometry.  Adoptive transfer of Ii-TGO B cells into 
Rag2-/- mice on dox promoted DO11 T cell division, but not to the extent that 
pOVA pulsed B cells promoted T cell division (Figure 2.2).  The DO11 cell 
division could have resulted from a host APC presenting OVA that was acquired 
from the adoptively transferred T cells, however, this result did confirm 
production of TGO by B cells. 
Sub-lethal irradiation eliminates large numbers of mature T and B cells, 
and could provide “space” for adoptively transferred T cells.  We skewed DO11 
Th2 cells in vitro which made IL-4 and IL-13, but not IFN-γ or IL-17A (Figure 
2.3A) Groups of dox-fed recipient mice were irradiated (400R) and then injected 
with naïve or activated DO11 Th2 cells.  Only a small percentage of adoptively 
transferred DO11 Th2 cells were recovered from the spleen at 6 weeks (Figure 
2.3B).  As early as 6 weeks after Th2 transfer, Ii-irradiated TGO mice produced 
autoantibodies with a predominantly antinuclear staining pattern (Figure 2.3C).  
Moreover, Ii-TGO mice receiving activated self-Ag-specific T cells also showed 
evidence of IgG and complement deposition in the kidney (Karen Lee’s thesis; 
data not shown).  Importantly, when comparing total Ig isotype titers of the ANA+ 
recipients, IgG2a and IgG2b only increased 2 fold (Figure 2.3D), suggesting that 
autoreactive B cells were preferentially activated by the DO11 Th2 cells, 
compared to other (non-autoreactive) B cells in the peripheral pool.  These 
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Figure 2.2. B cell expression of TGO can drive DO11 proliferation. 
 
5x106 CD4+ T cells from naïve DO11 mice and 5x106 Ii-TGO B cells were CFSE 
labeled and then adoptively transferred into Ii-TGO mice consuming normal chow 
or dox chow.  Prior to adoptive transfer, one set of B cells was pulsed with pOVA.  
At day 5 post-injection, spleens were harvested from mice and analyzed by flow 
cytometry for CFSE dilutions, CD4 and B220, to detect CD4+ T cells and B cells, 
respectively.  n=3-5 mice per group. 
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Figure 2.3. Activated Th2, but not naïve autoreactive T cells can elicit 
autoantibody production in Ii-TGO mice. 
 
(A) Intracellular cytokine staining from in vitro-differentiated DO11 Th2 cells 
cultured in the presence of irradiated syngeneic APCs with or without ova 
peptide.  Plots show cells within the DO11+ gate.  <APC-A> and <PE-A> are 
used as labels when APC or PE conjugated antibodies were omitted. 
(B) 5x106 DO11 Th2 cells were adoptively transferred into sublethally irradiated 
(4 cGy) Ii-TGO mice fed dox chow.  Spleens were harvested at 4 weeks and 
stained for CD4 and the DO11 TCR (KJ1-26) then analyzed by flow cytometry. 
(C) 5x106 naïve DO11 or DO11 Th2 cells were adoptively transferred into 
sublethally irradiated (4 cGy) Ii-TGO mice fed normal or dox chow.  Mice were 
cheek bled at 6 weeks and serum was analyzed by HEp2 ANA assay.  Images 
are representative of 4 experiments with 3-5 mice per group in each experiment. 
(D) Total antibody isotype concentration in Ii-TGO sera post T cell transfer was 
quantified by ELISA.  Each point represents an individual mouse. 
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results show that activated T cells can selectively activate autoreactive B cells 
present in the normal repertoire through cognate interactions. 
Non-induced TGO expression by radioresistant APCs drives extensive Treg 
development. 
At least two studies have shown that autoantibody production is dampened in 
mice immunized with self-Ag and adjuvant for a tissue-specific transgenic Ag if 
Ag-specific Tregs are present (Gotot et al., 2012; Ludwig-Portugall et al., 2009).  
Similarly, Tregs can decrease activation of anti-dsDNA B cells in response to T 
cell help (Seo et al., 2002).  Moreover, in previous studies, an unexpectedly high 
frequency of Treg cells were found in the thymus and skin draining lymph nodes 
of non-induced TGO mice crossed to DO11 mice, consistent with thymic TGO 
expression even in the absence of dox (Rosenblum et al., 2011).  Therefore we 
considered the possibility that Tregs could limit autoreactive B cell activation in 
unirradiated Ii-TGO mice.  I confirmed these results in our lab by generating 
DO11 x TRE-TGO and DO11 x Ii-TGO crosses.  Surface and intranuclear 
staining showed a marked increase in KJ1-26+ (DO11 anti-clonotype) 
CD25+Foxp3+ cells in DO11 x TRE-TGO mice.  Frequencies of Tregs in the KJ1-
26- compartment were within the normal range (Figure 2.4A).   
To determine whether the number of DO11 Tregs would increase in 
response to increased expression of TGO, I placed DO11 x Ii-TGO mice on dox 
chow or maintained them on normal chow for 7 days.  The total number of Tregs 
increased by roughly two-fold, and the total number of DO11 T cells increased by 
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an average of 50% (Figure 2.4B).    DO11 x Ii-TGO mice treated with dox chow 
exhibited a four-fold increase in the frequency of DO11 T cells expressing the 
marker of activation/Ag experience, CD69, and many co-expressed the lymph 
node-homing molecule CD62L.  Neither non-DO11 T cells in the same hosts, nor 
CD8+ T cells increased CD69 expression (Figure 2.4C).  These data show that 
TGO can induce activation of Ag-specific T cells in vivo, and that TGO 
upregulation further expands Ag-specific Tregs. 
To determine the relative contribution of radioresistant antigen presenting 
cells (rAPCs) compared to hematopoietically derived APCs (hAPCs) to Treg 
induction, we generated BM chimeras using T-depleted bone marrow obtained 
from either DO11 mice or [DO11 x TRE-TGO] F1 mice to reconstitute lethally 
irradiated BALB/c or TRE-TGO recipients.  In the BALB/c hosts, the majority 
(>80%) of thymic CD4 single positive (SP) T cells expressed the DO11 TCR, 
regardless of whether the donor BM was DO11 or DO11 x TRE-TGO, and only a 
small frequency (<0.5%) of these cells expressed Foxp3.  By contrast, in the 
TGO hosts, a lower percentage of the CD4 SP T cells were KJ1-26+, and of 
these only 15-22% were Foxp3+.  In the spleen, again both DO11! BALB/c and 
DO11 x TRE-TGO ! BALB/c chimeras had very few KJ1-26+ Tregs and 
relatively normal proportions of KJ1-26- Tregs.  However, in the TGO hosts, the 
vast majority of DO11 T cells appear to have been deleted since less than 20% 
of splenic CD4+ T cells were KJ1-26+.  Moreover, of the remaining KJ126+ cells, 
approximately one-third to one-half expressed Foxp3 (Figure 2.5A-B).  These 
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Figure 2.4. Ectopic expression of self-Ag drives extensive Treg 
development. 
 
(A) Single-cell suspensions from thymi, spleens, and lymph nodes of DO11 and 
DO11 x TRE-TGO mice were stained for CD4, CD8, CD25 and Foxp3 and 
analyzed by flow cytometry.  The flow cytometry plots shown were first gated on 
CD4 single positive events, and are representative of four DO11 mice and six 
DO11 x TRE-TGO mice. 
(B) DO11 x Ii-TGO mice were maintained on normal chow or fed dox chow for 7 
days.  Spleens were harvested and stained for CD4, DO11 TCR, CD25, and 
Foxp3.  Data are representative of three experiments with 3 mice per group.  
Bars represent SEM. 
(C) Splenocytes from DO11 x Ii-TGO mice on or off dox for 7 days were stained 
for CD62L and CD69 after gating on indicated T cell populations.  Gates shown 
above plots.  Data are representative of three experiments with 3 mice per group. 
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Figure 2.5. Non-induced expression of TGO by radioresistant APCs drives 
extensive DO11 deletion and proportional Treg increase. 
 
(A) Bone marrow chimeras were generated using lethally irradiated BALB/c or 
TGO hosts reconstituted with DO11 or DO11 x TRE-TGO bone marrow.  At 12 
weeks, thymi and spleens were analyzed for CD4, CD8, DO11 TCR (KJ1-26 
antibody), CD25, and Foxp3.  The flow cytometry plots shown were first gated on 
CD4 SP events.  These data are representative of two experiments with 3-4 mice 
per group. 
(B) Tabulation of data shown in (A).  The graph was generated from one 
experiment with 3 mice per group, and is representative of two experiments.  
Grey bars represent BALB/c hosts and black bars represent TGO hosts.  Error 
bar shows SEM. 
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data demonstrate that TGO expression in mice not given dox, and therefore not 
sufficient to induce the proliferation of mature DO11 T cells, could nevertheless: 
(a) lead to the deletion of developing DO11 Tg T cells and the proportional 
expansion of Tg-negative CD4+ T cells; and (b) induce the differentiation and/or 
expansion of DO11 Tg+ Tregs.  The data further indicated a negligible role for 
hematopoietically derived APC in this process.   
 
Absence of self-Ag bearing stromal cells is permissive to persistent 
autoreactive T cell activation and enhanced autoreactive B cell activity.  
The induction of lupus-like disease in Th2!Ii-TGO mice required irradiation, 
which may have provided functional inactivation of a regulatory population.  
Taken together with BM chimera data showing that rAPC-derived Ag was largely 
responsible for Treg generation (Figure 2.5), we next wanted to address whether 
the magnitude or specificity of B cell ANA production is limited by Ag-specific 
Tregs that could be driven by stromal-derived TGO.  To this end, we generated 
BM chimeras with negligible numbers of TGO-specific Tregs by reconstituting 
lethally irradiated non-Tg BALB/c mice with Ii-TGO bone marrow stem cells [Ii-
TGO! BALB/ chimeras].  We also reconstituted lethally irradiated Ii-TGO mice 
with Ii-TGO stem cells [Ii-TGO!Ii-TGO chimeras].  Twelve weeks after 
reconstitution, chimeric mice were placed on dox to induce TGO expression 
peripherally, but they were not sublethally irradiated as in the experiment 
described in Figure 2.3.  The chimeric mice were then injected with either naïve 
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DO11 cells, or DO11 Th2 cells, or left uninjected.  Six weeks later, serum 
samples collected from the mice were assayed for the presence of ANAs.  ANAs 
only developed in mice adoptively transferred with DO11 Th2 cells, suggesting 
that self-reactive (DO11) naïve T cell activation was effectively controlled even in 
the absence of self-Ag specific Tregs.  However, the Ii-TGO!BALB/c chimera 
hosts developed higher ANA titers than the Ii-TGO!Ii-TGO chimera hosts 
(Figure 2.6).  Unexpectedly, the frequency of activated non-Tg CD4+ T cells was 
similar in both BALB/c hosts and Ii-TGO hosts injected with Th2 cells (Figure 
2.7A), while B cell CD86 and MHC-II was markedly elevated in BALB/c hosts, but 
not TGO hosts (Figure 2.7B; CD86 not shown).  These data indicate that Ag 
specific Tregs may tune the quality of autoreactive B cell interactions with 
autoreactive T cells, even though they apparently fail to suppress T cell activation 
following an influx of activated self-reactive T cells. 
 
Activation and elaboration of Ag-specific SLO-resident Tregs are 
preferentially activated by rAPCs. 
The foregoing findings suggested a role for stromal self-Ag presentation in the 
control of aberrant activation and ANA production by B cells.  Because B cell 
activation and ANA production were reduced in the presence of TGO-expressing 
rAPC, we wanted to determine whether the Treg phenotype was enhanced by 
peripheral expression of TGO after development and poise Tregs to suppress 
autoreactive B cells.  To probe this question, we generated bone marrow 
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Figure 2.6. Absence of self-Ag bearing stromal cells is permissive ANA 
production by autoreactive B cells without sublethal irradiation. 
 
Ii-TGO!BALB/c and Ii-TGO!Ii-TGO bone marrow chimeras were created and 
reconstituted for 12 weeks.  At this time, the mice were not re-irradiated, they 
received an adoptive transfer of 5x106 DO11 Th2 cells or were not injected.  At 6 
weeks, sera from these mice were analyzed by HEp2 ANA assay.  Blinded 
scoring was performed using a 0-4 scale relative to BALB/c-Faslpr/lpr serum.  
Combined data from two experiments is shown.  A representative image to 
reflect the staining pattern is shown to the right of the graph. 
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Figure 2.7. Absence of self-Ag bearing stromal cells is permissive to 
increased B cell activation. 
 
Spleens were harvested from Ii-TGO!BALB/c and Ii-TGO!Ii-TGO bone marrow 
chimeras that were injected with naïve DO11 T cells or DO11 Th2 cells 12 weeks 
before.  Box plots show 5 mice per group and are representative of two 
experiments.  Flow plots are representative results from each group. 
(A) T cells were stained for markers of antigen experience/activation and 
analyzed by flow cytometry.  The KJ1-26- population is shown. 
(B) B cells were stained for MHC-II.  The gate for MHC-IIhigh cells was set against 
a normal BALB/c control spleen. 
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chimeras using DO11 x Ii-TGO F1 bone marrow stem cells to reconstitute lethally 
irradiated BALB/c or Ii-TGO hosts.  Twelve weeks after reconstitution, the mice 
were either kept on normal chow or placed on doxycycline chow for 7 days.  In 
accordance with our previous experiments (Figure 2.5), in both the normal chow 
and dox chow groups, the frequency and number of KJ1-26+ DO11 cells was 
decreased in Ii-TGO hosts relative to BALB/c hosts, and a large fraction of DO11 
cells in the Ii-TGO hosts co-expressed the Treg markers CD25 and Foxp3.  In 
the presence of dox, the total number of DO11 cells in both BALB/c and Ii-TGO 
hosts increased (Figure 2.8A-B), but remarkably, the number of DO11 Tregs only 
increased in Ii-TGO hosts (Figure 2.8C).  Moreover, in the presence of dox, the 
percentage of DO11 cells expressing both the activation marker CD69 and the 
lymph node homing receptor CD62L increased in both BALB/c hosts and Ii-TGO 
hosts.  Quite interestingly, over half of the CD69+CD62L+ T cells were also 
CD25+Foxp3+ Tregs in Ii-TGO hosts, but less than 10% of CD69+CD62L+ T cells 
in BALB/c hosts were Tregs (Figure 2.8D-E).  Both CD69 and CD62L expression 
by Tregs has been associated with more effective anti-inflammatory function in 
other models of sterile inflammation (Ermann et al., 2005; Fu et al., 2004; Szanya 
et al., 2002).  Our data indicate that a radioresistant peripheral host cell 
population bearing self-Ag most effectively activates and expands Tregs which 
home preferentially to SLOs by expression of the SLO homing molecule CD62L 
and could potentially suppress autoreactive B cell activation and ANA production.  
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Figure 2.8. Self-Ag presentation by radioresistant APCs drives activation 
and elaboration of SLO-tethered Tregs. 
 
DO11 x Ii-TGO bone marrow was used to reconstitute lethally irradiated BALB/c 
and TGO hosts.  At 12 weeks, the mice were either maintained on normal chow 
or placed on dox chow.  The mice were sacrificed 7 days later and spleen cell 
suspensions were stained and analyzed by flow cytometry.  Data are the 
combined results of two experiments.  Bars represent SEM. 
(A) Plot of the total number of cells staining positively with KJ1-26 within the 
CD4+ gate. 
(B) Plot of the frequency of cells staining positively with KJ1-26 within the CD4+ 
gate. 
(C) Plot of the total number and frequency of CD25+Foxp3+ cells within the KJ1-
26+ gate. 
(D) Plot of the total number and frequency of CD25+Foxp3+ cells within the KJ1-
26+ CD62L+ CD69+ gate. 
(E) Representative flow cytometry plots from DO11 x Ii-TGO!BALB/c or DO11 x 
Ii-TGO!TGO chimeras on dox. 
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In order to determine whether radioresistant lymph node stroma could (1) 
expand Tregs and (2) sustain or enhance CD62L expression on activated Tregs, 
we co-cultured CD25-purified cells from the spleen of a naïve DO11 x Ii-TGO 
mouse with CD45- (LNSC) or CD45+ cells from an Ii-TGO mouse.  Purity of the 
CD45- population was routinely >95% after magnetic depletion of CD45+ cells.  
Unfortunately, the addition of dox to LNSC cultures caused cell death—even at 
concentrations lower than what our lab has previously used to induce TGO in 
murine embryonic fibroblasts.  For this reason, the data I am including is from 
cultures in which pOVA was added to the CD45- and CD45+ cells to stimulate 
DO11 cells.  After 5 days of culture, I stained non-adherent cells from the 
cultures for CD25 and Foxp3.  Interestingly, in the absence of pOVA, the majority 
of DO11 x Ii-TGO T cells did not express Foxp3 (Figure 2.9A), although >80% 
expressed Foxp3 prior to being cultured.  In the presence of pOVA, regardless of 
whether CD45- or CD45+ cells were used as APCs, the frequency of Tregs was 
comparable to the pre-culture Treg frequency (Figure 9B).  This suggests that 
many of the Tregs in DO11 x Ii-TGO mice do not stably express Foxp3 without 
Ag-stimulation.  Despite the potential mixed stability of the Tregs in culture, 
LNSC cause upregulation of CD62L on Tregs only in the presence of pOVA, and 
CD45+ APCs promoted downregulation of CD62L (Figure 2.9B-C). 
To determine whether LNSC-mediated CD62L upregulation on Tregs was 
a Treg-specific phenomenon, we co-cultured CD45- stromal cells (purity shown in 
2.9D) or CD11c+ cells (largely dendritic cells (DC)), obtained from pooled lymph 
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Figure 2.9. Cognate Ag presentation by LNSC reinforces Treg capacity for 
lymph node homing. 
(A) CD25-purified DO11 x Ii-TGO T cells were cultured with CD45- and CD45+ 
cells from lymph nodes with or without pOVA.  At day 5, cultures were stained for 
Treg markers and analyzed by flow cytometry. 
(B) Cells from (A) were also stained for CD62L, and the frequency of CD62Lhigh 
cells is plotted.  Data in (A) and (B) are the combined results of two independent 
experiments.  Bars show SEM. 
(C) Histogram depicting log10 fluorescence of CD62L on DO11 Tregs after culture 
described in (A). 
(D) Representative plot of CD45- cell purity after CD45 depletion. 
(E) CD45- stromal cells or CD11c+ cells purified from pooled lymph nodes of Ii-
TGO mice were cultures with with CD4+ T cells from DO11-Foxp3eGFP x Ii-TGO 
mice.  Plot shows the frequency of CD62Lhigh cells within the KJ1-26+ eGFP+ 
gate. 
(F) Plot shows the frequency of CD62Lhigh cells within the KJ1-26+ eGFP- gate 
from the same cultures as (E).  The results shown are pooled from two 
experiments. 
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nodes of Ii-TGO mice, with CD4+ T cells from DO11-Foxp3eGFP x Ii-TGO mice.  
Activation by LNSC led to a modest decrease in CD62L by eGFP+ Tregs in the 
presence of pOVA, while CD11c+/T cell co-cultures led to a striking decrease in 
the frequency of CD62L+ Tregs (Figure 2.9E). Strikingly, although stroma-
directed reinforcement of CD62L expression was robust in the Treg population, a 
significantly lower frequency of eGFP- (non-Treg) T cells expressed CD62L 
(Figure 2.9F).  Thus we have identified a previously unrecognized player in 
dominant tolerance, the SLO stromal cell, which both activates and poises 
Foxp3+ Tregs to suppress activation of unprimed autoreactive T and B cells in 
spleen or lymph node through sustained expression of CD62L following 
activation.   
 
Discussion 
Chronic positive feedback loops due to sustained T cell-B cell interaction may 
drive systemic autoimmunity in diseases such as lupus.  In animal models of 
lupus, T cells promote IgG production from spontaneously activated autoreactive 
B cells, and B cells promote activation of autoreactive T cells.  Our work 
presented here broadens the understanding of how aberrantly activated 
autoreactive T cells may facilitate breakage of B cell tolerance.  Notably, our 
experiments examine the behavior of normal B cell repertoire, presumably 
including a small frequency of autoreactive B cells, which are availed of cognate 
interactions with T cells.  Autoantibody production by autoreactive B cells and 
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stimulation via CD40L and IL-21—mechanisms by which T cells enhance 
antibody responses—can be increased even by the provision of non-Ag-specific 
T cell help (Sweet et al., 2011).  We show that even with Ag-specific interactions, 
naïve T cells could not drive ANA production from endogenous autoreactive B 
cells.  DO11 T cells from naïve mice divide in Ii-TGO mice, but did not stimulate 
ANA production under conditions where activated DO11 T cells could stimulate 
ANAs.  Previous work has shown that naïve B cell Ag presentation to a naïve T 
cell results in hyporesponsiveness of the T cell (Fuchs and Matzinger, 1992), and 
it is likely that naïve DO11 T cells became anergic or proliferated abortively 
(Townsend and Goodnow, 1998).  This seems likely, since only a small number 
of DO11 T cell were recovered from spleens on unirradiated Ii-TGO mice.  From 
the available data, we cannot be certain that naïve T cells engage Ii-TGO B cells 
in vivo, since debris from Ii-TGO B cells could have been presented to DO11 T 
cells by a Rag2-/- host APC.  Although cognate interactions may not be required 
for Tg autoreactive B cells to receive T cell help, the nature of the autoAgs used 
to activate Tg B cells could have an impact on the B cell’s ability to respond. 
Autoreactive T cells specific for autoAgs that are commonly recognized by 
B cells are present at low levels in the T cell repertoire (Dumortier et al., 2000; 
Yan and Mamula, 2002), and T cells from autoimmune mice, which are 
presumably primed, stimulate autoantibody production from anti-snRNP Tg B 
cells (Yan and Mamula, 2002).  Activated DO11 Th2 cells did elicit ANA 
production in sublethally irradiated Ii-TGO mice, and this was likely due to 
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production of cytokines such as IL-21 and IL-4 (data not shown) and increased 
CD40L relative to naïve cells.  However, sublethal irradiation was required for Ii-
TGO mice to become ANA+ even after transfer of activated DO11 Th2 cells.  
There are several potential explanations for this finding.  First, irradiation 
provided immunological “space” for the large influx of activated cells, and the 
contraction of this population was therefore less sharp.  A second possibility is 
that irradiation provided apoptotic debris due to widespread lymphocyte death 
that served as autoAg.  This possibility is less likely, since we have no reason to 
believe that this cell debris persisted for the number of days required for B cell re-
emergence in the periphery (~11-13 days for follicular B cells).  A third possibility 
is that sublethal irradiation inactivated a regulatory cell population that 
suppressed DO11 Th2, autoAg-specific B cells, or both. 
We determined that expression of TGO by radioresistant host cells could 
drive Treg differentiation.  This effect was in part a proportional increase due to 
negative selection of DO11 T cells.  However, the administration of dox to DO11 
x Ii-TGO mice led to an increase in DO11 Tregs that could have been the result 
of peripheral induction of Tregs of modest proliferation of thymically derived 
Tregs.  The former seems more likely, since the majority of Tregs from DO11 x Ii-
TGO mice lost Foxp3 expression, suggesting that these cells were a less stable, 
peripherally induced population.  However, these data suggest that increasing 
TGO expression could induce Ag-specific Tregs or drive proliferation of existing 
Tregs.  We first approached this question by creating chimeric mice that have 
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virtually no TGO-specific Tregs, but could present TGO on hAPCs (Ii-
TGO!BALB/c), as well as chimeric mice that most likely had a population of 
TGO-specific Tregs, where TGO can be expressed by both rAPCs and hAPCs.  
Without sublethal irradiation, Ii-TGO!BALB/c chimeras became ANA+ after 
DO11 Th2, but not naïve DO11 injection, consistent our hypothesis that TGO 
presentation by rAPCs induced a radiosensitive regulatory cell population. 
Ii-TGO chimera experiments revealed that T and B cell activation was not 
suppressed evenhandedly in TGO hosts.  We found that expression of the 
marker of Ag experience CD44 and activation marker CD69 were upregulated on 
CD4+ KJ1-26- T cells in both Ii-TGO!BALB/c and Ii-TGO!Ii-TGO chimeras that 
were given dox and injected with Th2 cells, but this was not observed after 
injection of naïve cells (Figure 7).  Whether these activated T cells are oligoclonal 
or autoreactive is not known at this time, however, it suggests that autoimmunity 
in Ii-TGO!Ii-TGO chimeras was not prevented at the level of T cell activation.  
Interestingly, MHC-II upregulation correlated with increased ANA titer in the Ii-
TGO!BALB/c cohorts that were injected with Th2s.  Decreased MHCII on B 
cells suggests dominant tolerance, potentially exerted by Tregs, suppressed B 
cell activation.  Ideally, we would deplete Tregs specifically to test this 
hypothesis, and to this end, we plan to cross Ii-TGO onto a Foxp3-DTR mouse 
line.  Additionally, experiments to determine whether Tregs are eliminated or 
exhibit functional impairment in sublethally irradiated Ii-TGO mice should be 
performed. 
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TGO expression by rAPCs led to activation of DO11 Tregs (using CD69 
expression as criteria for activation) while maintaining expression of CD62L, 
which is usually downregulated after priming of naïve T cells (although it can later 
be upregulated) (Figure 8).  CD62L+ Tregs are potent suppressors of graft-
versus-host disease and in a model of type 1 diabetes, most likely because they 
home preferentially to lymph nodes and can suppress primary immune 
responses (Ermann et al., 2005; Fu et al., 2004; Szanya et al., 2002).  Since it 
was possible that a radioresistant, hematopoietically derived APC was 
responsible for the CD62L+ CD69+ DO11 Treg phenotype in DO11 x Ii-TGO BM 
chimeras, we used an in vitro culture system to examine stromal cell/Treg 
interactions.  Upregulation of CD62L on Tregs in these cultures suggests that the 
SLO stromal cells can activate and poise Foxp3+ Tregs to suppress activation of 
naïve autoreactive T and B cells in spleen or lymph node through sustained 
expression of CD62L following activation.  This phenomenon appears to be Treg 
specific, and the large presence of non-Tregs in CD4-purified cell/stromal cell 
cultures slightly abrogated CD69 maintenance on Tregs (Figure 9).  This may 
have been due to production of effector cytokines such as IFN-γ, which has been 
shown to act on LNSCs and enhance production of iNOS to regulate T cell 
division (Fletcher et al., 2010; Fletcher et al., 2011; Khan et al., 2011; Lukacs-
Kornek et al., 2011; Siegert et al., 2011).  I considered the possibility that sub-
lethal irradiation decreased the functional capacity of LNSC to regulate the 
proliferation of adoptively transferred DO11 Th2 cells.  If this were the case, it 
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could be a partial explanation for why irradiation was required to elicit ANA 
production in Th2!Ii-TGO mice (Figure 3).  This notion seems less likely given 
the results from DO11 x Ii-TGO BM chimeras, where rAPC were capable of 
expanding and activating DO11 Treg even after lethal irradiation.  The relative 
ability of LNSC to regulate specific Th subsets remains to be seen, but our data 
suggest that Treg:LNSC interactions and non-Treg:LNSC may have markedly 
different functional consequences. 
The results shown in this chapter demonstrate that T cell activation is an 
important checkpoint in the prevention of autoantibody production, that 
autoreactive T cell activation is sufficient for driving autoantibody production by 
autoreactive B cells, and that Ag-specific tolerance directed by rAPC—most likely 
Tregs—most effectively control autoantibody responses. 
 
 
Materials And Methods 
Mice 
BALB/c mice were purchased from the Jackson Laboratory and rested in our 
colony for at least one week before use.  Foxp3eGFP and DO11.10 mice were 
bred in-house after purchase from Jackson Laboratory.  DO11.10 Rag2-/- mice 
were bred in-house after purchase from Taconic.  All mouse experiments were 
approved by the Institutional Animal Care and Use Committee of the University of 
Massachusetts Medical School.  In all experiments, the mice were age-matched 
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within two weeks difference in date of birth. 
Doxycycline administration 
Mice were fed ad lib with doxycycline chow (200mg dox per kg of chow; Bioserv). 
Irradiation and bone marrow chimeras 
Mice were irradiated using a Cesium-137 irradiator in rotating containers.  For 
adoptive transfers of mature T cells, mice were dosed with 400 rads and injected 
the following day.  For lethal irradiation prior to bone marrow transfer, mice were 
dosed with 800 rads and injected the following day.  Bone marrow was flushed 
from femurs and tibias of naïve donors using a 25 gauge needle and syringe and 
cold sterile PBS + 2% FBS.  The cells were spun-down and re-suspended in 
complete RPMI.  T cells were depleted using supernatants from hybridomas 
secreting GK1.5 (anti-CD4) and (53-67.2) anti-CD8 and complement.  The cells 
were washed twice in complete RPMI and twice in sterile PBS.  10x106 bone 
marrow cells were injected into mice that had received 800 rads on the previous 
day. 
Flow cytometry 
Single cell suspensions were surface or intracellular stained with combinations 
the following antibodies: I-A/I-E-FITC, CD3 (clone 145-2C11), CD4 (clone RM4-
5), CD8α (clone 53-6.7), CD25-PerCP-Cy5.5 (clone PC61.5), CD69-efluor450, 
CD62L-APC-efluor780, B220, Foxp3-PE (clone FJK-16s) all from eBioscience, 
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and CD45-APC (Miltenyi).  For Foxp3 staining, cells were fixed and 
permeabilized using the Foxp3 Transcription Factor staining buffer kit 
(eBioscience) according to the manufacturers instructions. 
 
In vitro T cell differentiation and transfer  
CD4+ T cells were purified from DO11 lymph node and spleen cell suspensions 
by positive selection (BD iMag CD4 beads; manufacturer’s instructions).  RPMI 
medium 1640 (cRPMI; Life Technologies, Grand Island, NY), containing 10% 
FCS (Sigma), 10 µM 2-mercaptoethanol, 100 units/ml penicillin, 0.1 mg/ml 
streptomycin, and 0.3 mg/ml glutamine (GIBCO) was used for cell culture. 
 Cells cultures were stimulated with irradiated BALB/c spleen (3,000 rads; 1:5 
ratio of T cells to irradiated spleen) for 48-72 hours in the presence of pOVA 
(1µg/ml; Genscript), X63.Il4 supernatant (1:4) and, X63.Il2 supernatant (2 drops 
per 5ml).  Cells were split on day 2 and then as needed.  Cultures were 
supplements with X63.Il2 supernatant each time cells were split.  On day 7-9, 
when T cells had rounded in shape, cultures were re-stimulated with irradiated 
BALB/c spleen (3,000 rads) for 48-72 hours in the presence of pOVA.  5x106 
cells were injected per mouse i.v.  “Naïve” DO11 cells were CD4 purified from 
lymph node and spleen suspensions, washed in PBS, and 5x106 cells were 
injected per mouse i.v.   
 
CFSE Labeling 
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Before labeling, cells were washed twice in sterile PBS and re-suspended at a 
concentration of 5x106/ml.  A 5mM stock solution of CFSE (Invitrogen) was 
diluted in PBS (1:2,000) in a volume equal to the cell suspension.  The two 
populations were combined using a serological pipet and mixed thoroughly.  The 
tube of cells was covered in foil and incubated at 37°C for 5 minutes.  The cells 
were washed three times in PBS + 2% FBS and prepared for adoptive transfer. 
 
HEp2 ANA assay 
Sera were diluted 1:50 in PBS and placed on HEp2 ANA slides.  BALB/c-Faslpr/lpr 
serum and normal BALB/c serum were used as positive and negative controls.  
After 60 minutes at room temperature, the slides were washed twice in a Coplin 
jar filled with fresh PBS, with rocking, for 5 minutes.  Slides were then stained 
with anti-mouse IgG-FITC (Southern Biotech).  After 30 minutes at room 
temperature, the slides were washed as above, dipped in tap water, and 
mounted with ProLong Gold (Invitrogen). 
 
Stromal cell and CD11c+ cell isolation 
Lymph nodes and spleens were placed in a Petri dish containing pre-warmed 
RPMI with 2% FBS containing 0.5mg/ml dispase and 0.5 mg/ml collagenase.  
The tissues were gently mechanically disrupted with frosted glass slides briefly, 
and then incubated for 15 minutes at 37°C.  A sterile P1000 pipet tip was cut with 
an autoclaved razor to increase the size of the opening.  This large-bore tip was 
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used to disrupt the tissues by pipetting.  The enzyme cocktail was removed by 
pipetting and washed four times with cRPMI.  Fresh enzyme cocktail was added 
to the remaining solid tissue, and this process was repeated twice more. 
After four washes, single cell suspensions of lymph nodes and spleen were used 
for CD11c positive selection or CD45 depletion (Miltenyi; according to 
manufacturer’s instructions). 
 
Statistical methods 
Data analysis was performed using Prism (GraphPad) software.  p values were 
calculated using unpaired two-tailed Student’s t test.  In all figures, ns (not 
significant) denotes a p>0.05, *, p≤0.05, **,p≤0.01, ***,p≤0.001. 
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CHAPTER III 
IL-21 Drives Pulmonary Fibrosis through the Induction of Pro-fibrotic CD8+ 
T Cells 
Introduction 
Fibrosis, defined as the excess production and accumulation of extracellular 
matrix components, is the final common pathway of many chronic inflammatory 
conditions (Wick et al., 2013; Wynn, 2004).  Despite the prevalence of fibrosis as 
both a primary disease and a consequence of common chronic diseases such as 
asthma, sarcoidosis, and heart failure, there are currently no FDA-approved 
treatments that specifically target fibrogenesis (Wynn and Ramalingam, 2012).  
Idiopathic pulmonary fibrosis (IPF) is a progressive condition with a poor 
prognosis and minimal therapeutic options.  Fibrotic interstitial lung disease also 
occurs in autoimmune diseases such as systemic sclerosis (SSc), and 
rheumatoid arthritis (Wick et al., 2013; Wynn, 2004, 2011; Wynn and 
Ramalingam, 2012). In these diseases, cells that are beneficial during normal 
tissue repair, such as macrophages, T cells, and fibroblasts, drive an excessive 
tissue repair response (fibrosis), leading to organ dysfunction (Wynn, 2004, 
2011). 
Activation of fibroblasts by TGF-β and consequent collagen production is 
crucial for both wound healing and fibrosis.  Additionally, Th2 cell derived IL-4 
and IL-13 are integral components of the wound healing response due to the 
ability of these cytokines to activate fibroblasts (Wynn, 2004, 2011).  IL-13 is also 
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a potent stimulus for macrophage production of TGF-β (Lee et al., 2001), and 
can drive lung fibrosis in the absence of other lung injury (Lee et al., 2001).  
Importantly, Th2-associated cytokines become aberrantly upregulated in fibrosis.  
Because CD4+ T cells have effector functions in murine models of SSc (Radojcic 
et al., 2010; Wallace et al., 1994) and pulmonary fibrosis (Pesce et al., 2006; 
Wilson et al., 2010), many studies have examined the role of T cell cytokines 
such as IFN-γ, IL-4 and IL-13 in tissue pathology.  Importantly, IL-13 has been 
linked to human disease and CD8+ T cells by a number of studies. IL-13 
expression is significantly elevated in IPF (Murray et al., 2013), IL-13 is present 
in IPF patient lung lavage fluid, fibroblasts from IPF patients are hyper-
responsive to IL-13 (Wynn, 2011), and SSc patients were shown to have a 
predominantly Th2/Tc2-biased T cell pool (CD4+ and CD8+) (Wynn, 2004).  
Furthermore, CD8+ T cells from SSc patients have been reported to secrete IL-13 
and stimulate fibroblasts in an IL-13 dependent manner (Fuschiotti et al., 2013).  
Lung function decline has also been associated with type 2 skewed CD8+ T cells 
in SSc (Atamas et al., 1999).  Nevertheless, neither the actual roles of activated 
Tc2 cells relative to Th2 cells nor the genesis of Tc2 cells in vivo is well 
understood.  
Development of murine pulmonary fibrosis following bleomycin treatment, 
a sterile lung injury model, requires both an early Th17 (Oh et al., 2011; Wilson et 
al., 2010) response, and an IL-13 response (Belperio et al., 2002; Fichtner-Feigl 
et al., 2006; Jakubzick et al., 2003) which is somewhat more delayed (Wilson et 
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al., 2010).  Asthma, which is often accompanied by subepithelial fibrosis, is a 
largely Th2-driven disease, and a role for Tc2 cells remains controversial (Das et 
al., 2006; Miyahara et al., 2004).  Fibrosis associated with schistosomiasis also 
requires IL-13 production, and CD4+ T cells are the main producers of IL-13 in 
these systems (Wynn, 2004).  It has therefore been presumed that CD4+ T cells 
are the sole source of IL-13 in sterile fibrosis, although, this has not been 
definitively shown.  However, in a rarely cited report, depletion of CD8+ T cells 
appears to almost completely prevent bleomycin-induced pulmonary fibrosis 
(Piguet et al., 1989), as does perforin deficiency (Miyazaki et al., 2004).  Thus we 
reasoned that the relative contribution of Th2 and Tc2 cells to the fibrotic process 
warranted further investigation. 
CD4+ T cells, including Th17 cells, and NKT cells secrete IL-21.  IL-21 is a 
highly pleiotropic cytokine, which, in combination with other cytokines, amplifies 
the function of both CD4+, and CD8+ T cells (Liu and King, 2013; Spolski and 
Leonard, 2008).  Interestingly, IL-21 has been implicated in induction of both Th2 
(Frohlich et al., 2007; Pesce et al., 2006) and Th17 (Korn et al., 2007) cells, and 
as such, could provide a bridge for the progression from a Th17 to a Th2 
response in the fibrosing lung.  Furthermore, in human fibrotic lung samples, 
expression of IL-21 receptor (IL-21R) has been detected in lymphocytic 
infiltrates, suggesting that IL-21 responsive lymphocytes may be involved in lung 
fibrosis (Parrish-Novak et al., 2000; Parrish-Novak et al., 2002).  In mice, IL-21R 
deficiency attenuated collagen deposition in the liver caused by parasitic infection 
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(Pesce et al., 2006).  Taken together, these data implicate IL-21 as potentially 
deleterious in pulmonary fibrosis.  We now show that IL-21 plays a critical role in 
the activation and expansion of IL-13 producing Tc2 cells, which in turn function 
as a critical link between inflammation and fibrosis. 
 
Results 
IL-21R signaling drives fibrosis but is dispensable for inflammation after 
sterile lung injury.   
To determine whether IL-21 plays a role in a sterile lung injury model of 
fibrosis, we compared the effects of intratracheal (i.t.) instillation of bleomycin in 
wild type C57BL/6 (B6) mice and IL-21 receptor knockout (Il21r-/-) B6 mice at 
days 14 and 21 post treatment.  By histological analysis, lung inflammation was 
comparable between B6 and Il21r-/- mice as hematoxylin and eosin (H&E) 
staining indicated a similar extent of mononuclear cell infiltration, with the 
majority of the infiltrate being granulocytes (Figure 3.1A).  To further compare the 
B6 and Il21r-/- mice, we determined the actual number of cells in bronchoalveolar 
lavage fluid (BALF) and lung draining (mediastinal) lymph nodes (LDLN) at day 
14.  In accordance with the histopathology, Il21r-/- mice treated with bleomycin 
had BALF and LDLN cell numbers that were similar to B6 mice treated with 
bleomycin, but markedly increased compared to PBS-treated control mice 
(Figure 3.1B).  However, there was a striking attenuation in peribronchiolar 
fibrosis in Il21r-/- mice at both days 14 and 21 after bleomycin injury, as detected 
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Figure 3.1. IL-21R deficiency does not protect from bleomycin-induced lung 
inflammation. 
 
B6 and Il21r-/- mice were treated with bleomycin (bleo; 0.05U/mouse) or PBS 
(control) i.t. and sacrificed at day 14.   
(A) Formalin-fixed, paraffin-embedded lung sections were stained by H&E. 
Magnification = 20X. 
(B) LDLN and BALF cells were collected at day 14 and cell numbers/mouse were 
determined.  Data are compiled from three independent experiments (PBS!B6, 
n=6; PBS!Il21r-/-, n=4; Bleo!B6, n=10; Bleo!Il21r-/-, n=11.  Bar indicates 
median ± SEM. 
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by Masson’s trichrome staining (Figure 3.2A and data not shown).  In addition, 
quantification of collagen concentration in lung extracts at 14 days by a 
colorimetric collagen binding assay confirmed that both Il21r-/- and IL-21-
deficient (Il21-/-) mice had significantly decreased collagen deposition in the lung 
compared to bleomycin-treated B6 mice (Figure 3.2B).    
 To determine whether fibroblasts in Il21r-/- mice became activated after 
bleomycin injury, lung sections were stained for α-smooth muscle actin (α-smAc), 
a protein expressed by collagen-producing myofibroblasts upon activation.  
Remarkably, α-smooth muscle actin was readily detected in the bleomycin 
injected B6 mice but completely absent from the Il21r-/- mice (Figure 3.2C). In 
addition, survival of Il21r-/- mice in response to high-dose bleomycin was 
prolonged compared to B6 controls (Figure 3.2D). Together, these results identify 
IL-21 signaling as a critical event in the transition between inflammation and 
fibrosis. 
 
CD8+ T cell recruitment is impaired in Il21r-/- mice after sterile lung injury. 
 Several lines of evidence demonstrate that T cells have an integral role in 
the transition from inflammation to fibrosis, thus we wanted to determine whether 
decreased T cell recruitment or activation was responsible for attenuated 
pulmonary fibrosis in Il21r-/- mice.  At day 14 post-bleomycin injury, we stained 
single-cell suspensions of LDLN cells for T cell surface markers and markers of 
activation.  The frequency of CD8+ T cells was significantly decreased in the 
67
Figure 3.2. IL-21R signaling is required for fibrosis following bleomycin-
induced lung inflammation. 
 
(A) Lung sections were stained with Masson’s Trichrome. Magnification =20X. 
(B) Lung extracts were quantitated for collagen concentration by a colorimetric 
assay.  Data are representative of three independent experiments (PBS!B6, 
n=6; PBS!Il21r-/-, n=4; Bleo!B6, n=11; Bleo!Il21r-/-, n=11; Bleo!Il21-/-, 
n=5).  Data shown are means ± SEM. 
(C) Lung sections harvested at day 14 were stained for α-smooth muscle actin to 
detect activated fibroblasts. 
(D) Survival of B6 and IL21R-/- mice depicted following high-dose bleomycin 
treatment (0.15U/mouse); (B6 n=5; Il21r-/- n=4). 
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LDLN of Il21r-/- mice compared to B6 controls after bleomycin injury.  
Furthermore, Il21r-/- mice had roughly half (an average of 48% less than B6) the 
frequency and number of CD8+ T cells infiltrating the lung (Figure 3.3A) and 
LDLN (Figure 3.3B) compared to B6 mice after bleomycin injury.  The total 
average number of CD4+ T cells was decreased by only 30% in Il21r-/- mice 
compared to B6 controls after bleomycin treatment (Figure 3.3B).  The ratio of 
CD4+ to CD8+ T cells was also significantly increased in bleomycin-treated Il21r-
/- mice (Figure 3.3C). However, expression of the activation marker CD69 on 
both CD4+ and CD8+ T cells was comparable between bleomycin-treated B6 and 
Il21r-/- mice (Figure 3.3D).  CD4+ CD25+ Foxp3+ regulatory T cells (Tregs) can 
dampen inflammation, including T cell responses (Shevach, 2009).  However, the 
frequency of Tregs in LDLN of Il21r-/- mice was not increased relative to B6 
mice, suggesting that Tregs are not likely to be responsible for decreased CD8+ 
proliferation or recruitment (Figure 3.4).  These data show that IL-21 is a key 
factor in maximizing the CD8+ T cell response during lung fibrogenesis, and has 
a lesser effect on the CD4+ T cell response. 
 
Protection from fibrosis in Il21r-/- mice is associated with a decrease in IL-
13, but not IL-17A, production by T cells. 
IL-17A has been identified as a pro-fibrotic mediator in the bleomycin 
model (Oh et al., 2011; Wilson et al., 2010), however, it is dispensable in other 
models of fibrosis (Lo Re et al., 2010).  Because IL-21 is an amplifier of both 
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Figure 3.3. IL-21/IL-21R interactions are required for optimal CD8+ T cell 
recruitment to the lung following bleomycin injury. 
 
B6 and Il21r-/- mice were treated with bleomycin (bleo; 0.05U/mouse) or PBS 
(control) i.t. and sacrificed at day 14.   
(A) At day 14, LDLN cell suspensions were analyzed by flow cytometry for CD4+ 
and CD8+ T cell frequency. 
(B) Summary of the total number of CD4+ and CD8+ T cells in LDLN at day 14.   
(C) From data above, the ratio of CD4+ T cells to CD8+ T cells was determined. 
(D) LDLN T cell activation at day 14 was analyzed by flow cytometry for surface 
expression of CD69.  Data are compiled from two independent experiments with 
similar results. (PBS!B6, n=6; PBS!Il21r-/-, n=4; Bleo!B6, n=8; Bleo!Il21r-/-, 
n=8) 
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Figure 3.4. Increased Treg activity is not responsible for protection from 
fibrosis in IL-21R deficient mice. 
 
LDLN Treg frequency at day 14 was assessed by co-expression of CD25 and 
Foxp3 in the CD4+ gate as determined by flow cytometry. Data are compiled from 
two independent experiments with similar results. (PBS!B6, n=6; PBS!Il21r-/-, 
n=4; Bleo!B6, n=8; Bleo!Il21r-/-, n=8) 
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Th17 and Th2 responses (Frohlich et al., 2007; Korn et al., 2007), one question 
that remains is to what extent IL-21 promotes Th17 or Th2 responses within a 
microenvironment that favors the differentiation of both.  To investigate the role of 
IL-21 in pro-fibrotic Th2 and Th17 responses, we analyzed LDLN T cells for 
cytokine production.  At day 14 following intratracheal bleomycin injury, single-
cell suspensions of LDLN cells obtained from PBS and bleomycin treated mice 
were stimulated in vitro with plate-bound anti-CD3 for 24 hours and supernatants 
were then analyzed by ELISA for IL-17A, as a readout of Th17 cells, and IL-13, 
as a readout for Th2 cells.  T cells from the bleomycin treated B6 and Il21r-/- 
mice made comparable amounts of IL-17A (Figure 3.5A).  However, T cells from 
bleomycin treated Il21r-/- mice secreted three-fold less IL-13 than those from 
bleomycin treated B6 mice (Figure 3.5B). Surprisingly, as determined by 
intracellular cytokine staining of T cells from LDLN, Il21r-/- mice had a 
significantly lower frequency of IL-13 producing CD8+ T cells (Figure 3.5C-D).  
The decreased frequency of IL-13 producing CD8+ T cells, taken together with 
the decreased total number of CD8+ T cells (Figure 3.3B) resulted in strikingly 
fewer IL-13 producing CD8+ T cells overall.  These data indicate that bleomycin-
induced CD8+ T cell differentiation into pro-fibrotic, type 2 effectors is highly 
dependent on IL-21.  Preliminary data from human tissue confirms IL-13 
upregulation in fibrotic disease (Figure 3.5E). 
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Figure 3.5. Lack of IL-21R significantly impairs IL-13 production in 
response to sterile lung injury.   
 
(A, B) LDLN cell suspensions collected from PBS and bleo-treated mice at day 
14 were stimulated with anti-CD3 and culture supernatants were harvested 24 
hours later and assayed for IL-17A and IL-13 by ELISA.  Data are compiled from 
two independent experiments with similar results.  (PBS! B6, n=6,  Bleo!B6, 
n=9; Bleo!Il21r-/-, n=7). 
(C, D) LDLN T cells from bleo-treated were re-stimulated and cytoplasmic 
staining was performed for IL-13. Data in C are compiled from three independent.  
(Bleo!B6, n=12; Bleo!Il21r-/-, n=10).  Data in D are representative of three 
independent experiments that yielded similar results. 
(E) Formalin-fixed, paraffin-embedded lung tissue sections from SSc patients 
and healthy controls were stained for IL-13 by immunohistochemistry.  Positive 
IL-13 staining was observed in three SSc sections and not in any of three 
samples of healthy lungs. 
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IL-21 promotes Tc2 differentiation in vivo and in vitro 
After determining that IL-21 had a role in bleomycin-induced fibrosis, we 
sought to determine the cellular source of IL-21.  In accordance with a previous 
study using IL-21 reporter mice (Spolski et al., 2012), we found that a small 
population of CD4+ T cells produces IL-21 in the lung constitutively (Figure 3.6A) 
and these T cells preferentially express both CD44, a marker of antigen 
experience, and CD62L, an adhesion molecule that controls migration to lymph 
nodes.  The frequency of IL-21+ CD4+ T cells that co-expressed CD44 and 
CD62L was roughly ten-fold higher than CD44/CD62L double positive CD4+ T 
cells in the total population (Figure 3.6B), suggesting that these cells could be 
part of a memory-like pool.   To identify the source of IL-21 following lung injury, 
we instilled bleomycin i.t. and harvested lungs at day 7.  Single-cell suspensions 
from lung tissue were stimulated in vitro for cytoplasmic staining.   Quite 
unexpectedly, i.t. bleomycin induced IL-21 production from both CD4+ and CD8+ 
T cells in the lung (Figure 3.6C).   
Since IL-21R deficiency had shown such dramatic effects on bleomycin 
induced fibrosis and the frequency of CD8+ T cells, we next asked whether IL-21 
by itself could elicit fibrosis and CD8+ T cell production of IL-13 in lung.  
Cytoplasmic staining of lung tissue leukocytes from mice treated with rmIL-21 
showed that by day 7, a remarkably high frequency of CD8+ cells were producing 
IL-13 (Figure 3.7A).  Strikingly, at day 10, mice treated with rIL-21 i.t. showed 
evidence of inflammation and fibrosis, which was detected histologically by H&E 
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Figure 3.6.  IL-21 is constitutively expressed by a small population of lung 
CD4+ T cells, and is upregulated in both CD4 and CD8 T cells in response to 
bleomycin or IL-21 i.t. 
 
(A) Single cell suspensions from lungs of untreated B6 and Il21-/- mice were 
stimulated with PMA/ionomycin in the presence of GolgiStop for 5 hours.  
Intracellular IL-21 in CD4, CD8, and γδ T cells was analyzed by flow cytometry 
after surface and cytoplasmic staining.  
(B) CD44 and CD62L expression of CD4+ IL-21+ cells (the population for the 
gate in A) was determined by flow cytometry.  For A-B, results are from two 
independent experiments.  (B6 n=6, Il21-/- n=2).   
(C) B6 mice were treated with PBS, bleomycin (0.05U/mouse) or rmIL-21 
(1µg/ml) i.t.  On day 7, lung leukocytes were stimulated with anti-CD3 in the 
presence of GolgiStop and stained for intracellular IL-21. (PBS n=2, bleo n=5, IL-
21 n=4).   
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and trichrome stains (Figure 3.7B) and by quantitative collagen assay (Figure 
3.7C). Thus, IL-21 drives CD8+ T cells to differentiate into cells that produce IL-
13 and IL-21 (Tc221 cells), and can drive fibrosis even in the absence of other 
lung injury. 
 
The combination of IL-4 and IL-21 efficiently promotes the in vitro 
differentiation of CD8+ T cells into Tc221 cells. 
IL-21 can enhance cytokine production by Th2 cells through autocrine and 
paracrine mechanisms (Stritesky et al., 2011). To better understand how IL-21 
promotes the differentiation of Tc221 cells, we decided to evaluate the importance 
of IL-21 and other cytokines in the in vitro generation of Tc221 cells. It has 
previously been reported that Tc2 cells require IL-2 and IL-4 for differentiation 
(Croft et al., 1994; Sad et al., 1995).  However, IL-2 is not strongly upregulated in 
the lungs in response to bleomycin injury (Gur et al., 2000).  Moreover, many IPF 
patients do not exhibit IL-2 upregulation (Homolka et al., 2003; Kitasato et al., 
2004).  Therefore, we sought to determine whether IL-21 was sufficient for Tc2 
differentiation in vitro as determined by IL-13 production.  We activated purified 
CD8+ T cells and assessed the ability of IL-21 to support their capacity to 
produce IL-13 in conjunction with IL-4, with or without IL-2.  We found that IL-21 
could supplant IL-2 in Tc2 differentiation, and no synergistic effect was observed 
by adding both IL-2 and IL-21 (Figure 3.8). 
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Figure 3.7.  Sterile lung injury and IL-21 drives Tc2 differentiation in the 
lung and fibrosis.   
  
(A) B6 mice were treated with PBS, bleomycin (0.05U/mouse) or rmIL-21 
(1µg/ml) i.t.  On day 7, lung leukocytes were stimulated with anti-CD3 in the 
presence of GolgiStop and stained for intracellular IL-21 and IL-13. (PBS n=2, 
bleo n=5, IL-21 n=4).   
(B) BALB/c mice were treated with a single instillation of rmIL-21 i.t. and at day 
10, lungs were harvested and formalin fixed, paraffin-embedded sections stained 
by H&E and Masson’s Trichrome. Magnification = 20X.   
(C) Collagen concentration in lung extracts from mice in (B) was measured by 
colorimetric assay.  Bars represent means ± SEM.  In (B) and (C) Results shown 
are compiled from four independent experiments with three to four mice per 
group. 
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Figure 3.8.  IL-21 drives Tc2 differentiation in vitro.   
 
Purified splenic CD8+ T cells from naïve B6 mice were cultured in the presence 
of the indicated cytokines for 4 days.  The cells were then re-stimulated using 
anti-CD3 in the presence of GolgiStop and cytoplasmic staining for IL-13 was 
performed.  A representative flow cytometry plot is shown.  Data are 
representative of five independent experiments. 
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Tc2 cells self-prime with IL-21. 
Since Th17 cells can be amplified by autocrine and/or paracrine IL-21 during 
differentiation (Wei et al., 2007), we hypothesized that autocrine IL-21 could 
amplify Tc2 differentiation.  Using an in vitro activation system, we skewed wild 
type and IL-21-deficient purified CD8+ T cells using IL-2 or IL-21 with or without 
IL-4.  Intriguingly, only IL-21/IL-4, but not IL-2/IL-4 or IL-21 alone, generated 
effectors capable of copious IL-21 secretion by CD8+ T cells upon re-stimulation 
as measured by ELISA (Figure 3.9A).  We confirmed IL-21 production using 
primary splenic CD8+ T cell cultures from IL-21-mKate fluorescent reporter mice 
(Figure 3.9B).  Moreover, in accordance with our hypothesis, there was a striking 
difference in IL-13 production by IL-21-deficient and IL-21 sufficient Tc2 cultures.  
IL-21-deficient CD8+ T cells did not secrete IL-13 when treated with IL-21 and IL-
4, but wild type B6 CD8+ T cells secreted high levels of IL-13 (Figure 3.9C).  
Therefore, paracrine IL-21 drives CD8+ T cell secretion of IL-21, which in turn 
promotes IL-13 production through an autocrine pathway.   
To determine whether Tc2 (IL-2 cultured) and Tc221 cells had differing 
ability to drive fibrosis in vivo, we generated OT-I (ova-specific) effectors 
activated in the presence of IL-4, IL-4 + IL-2, or IL-4 +IL-21.  We adoptively 
transferred activated OT-1 cells into mice expressing membrane-bound ova 
under the lung-specific CC10 promoter (CC10-ova mice).  Injection of IL-4 + IL-2 
activated OT-I Tc2 cells caused a modest increase in BAL cell number but no 
increase in BAL collagen.  IL-4 + IL-21 activated OT-I Tc2 cells caused both an 
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Figure 3.9. Autocrine IL-21 promotes Tc2 phenotype.   
 
(A) Purified splenic CD8+ T cells from naïve B6 mice were cultured in the 
presence of the indicated cytokines for 4 days.  The cells were then re-stimulated 
using anti-CD3 without additional cytokines.  Cell supernatants were harvested at 
24 hours and assayed for IL-21 by ELISA.  Data shown are compiled three 
independent experiments.  Data shown are means ± SEM. 
(B) Purified splenic CD8+ T cells from IL-21-mKate reporter mice were cultured in 
the presence of the indicated cytokines for 4 days.  The cells were analyzed by 
flow cytometry without re-stimulation.  Representative of two experiments. 
(C) Purified CD8+ T cells from WT and Il21-/- mice were stimulated as indicated 
and the concentration of IL-13 in the culture supernatants was determined.  
Representative of three independent experiments.  Data shown are means ± 
SEM. 
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increase in BAL cell number and collagen (Figure 3.10).  These data indicate that 
naïve T cells activated in the presence of IL-4 and IL-21 preferentially acquire 
pro-fibrotic activity. 
 
CD25 signaling and TGF-β regulate Tc2 differentiation. 
We next wanted to determine whether IL-2 signaling impacted Tc2 
differentiation in response to IL-4 + IL-21.  Quite interestingly, blockade of the 
high-affinity IL-2 receptor, CD25, enhanced IL-13 production almost two-fold at 
the expense of IFN-γ production (Figures 20A-B), suggesting that upon 
activation, high-affinity IL-2 signaling does not drive CD8+ T cells into Tc1 and 
Tc2 differentiation pathways evenhandedly, but rather inhibits Tc2 differentiation. 
TGF-β has both potent pro-fibrotic and anti-inflammatory functions.  To 
understand how these roles affected Tc2 differentiation, we also skewed Tc2 
cells in the presence of TGF-β.  As expected, TGF-β limited proliferation of CD8+ 
T cell cultures (data not shown). However, the TGF-β treated CD8+ T cells did 
produce IFN-γ, but not IL-13 (Figures 3.11A-B). Additionally, we found that TGF-
β in conjunction with IL-4 decreased the level of IL-21R expression (Figure 
3.11C), thereby downregulating CD8+ T cell responsiveness to IL-21.  We again 
used CD8+ T cells purified from IL-21 reporter spleen, and found that TGF-β 
caused a decrease in IL-21 production (Figure 3.11D), concomitant with 
decreased IL-21 sensitivity (Figure 3.11C).  This effect was not induced by either 
TGF-β or IL-4 alone. This finding suggests that while TGF-β has indispensable 
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Figure 3.10. Tc221 cells are profibrotic in vivo.   
 
Purified splenic CD8+ T cells from naïve B6 mice were cultured in the presence 
of the indicated cytokines with IFN-γ neutralization (30µg/ml) for 6 days.  The 
cells were then re-stimulated using anti-CD3 and anti-CD28 without additional 
cytokine.  Two days after re-stimulation, 5x106 T cells were injected per mouse.  
BAL fluid was harvested after sacrifice and assayed for collagen 1A1 by ELISA. 
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pro-fibrotic effects on stromal cells such as fibroblasts, it negatively regulates 
pro-fibrotic CD8+ T cells.  Taken together, these data indicate that IL-21 can 
supplant IL-2 to promote Tc2 differentiation during fibrogenesis, and that high 
affinity IL-2R signaling and TGF-β counter-regulate the effects of IL-21 signaling. 
 
IL-21R-sufficient CD8+ T cells restore fibrotic phenotype of IL-21R-deficient 
mice. 
As shown above, CD8+ T cell numbers and function were most impacted 
by IL-21R deficiency in the in vivo bleomycin-induced fibrosis studies, and CD8+ 
T cells also produced large amounts of IL-13 when activated in vitro the presence 
of IL-21 + IL-4.  Therefore we considered the possibility that IL-21-responsive 
CD8+ T cells are required for lung fibrosis in response to sterile lung injury. To 
test this hypothesis, purified splenic B6 CD4+ or CD8+ T cells from untreated 
mice were adoptively transferred into both B6 and Il21r-/- mice and the recipients 
were subsequently treated with bleomycin.  LDLN were then collected at day 14, 
re-stimulated ex vivo with plate-bound anti-CD3, and assayed for cytokine 
production by ELISA.  Remarkably, injection of B6 CD8+ T cells “rescued” 
defective IL-13 production by LDLN T cells from bleomycin treated Il21r-/- 
recipients, but had little effect on the IL-13 response of B6 recipients (Figure 
3.12A).  In contrast, LDLNs from the B6 and Il21r-/- recipients produced similar 
levels of IFN-γ (Figure 3.12B), and thus it is unlikely that the adoptively 
transferred T cells enhanced fibrosis by developing into tissue destructive, type 1 
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Figure 3.11.  CD25 signaling and TGF-β regulate Tc2 differentiation in vitro.  
  
(A-B) Purified splenic CD8+ T cells from naïve B6 mice were cultured in the 
presence of the indicated cytokines and antibodies for 4 days.  The cells were 
then re-stimulated using anti-CD3 in the presence of GolgiStop and cytoplasmic 
staining for IL-13 and IFN-γ was performed.  A representative flow cytometry plot 
is shown in A.  Bars represent means ± SEM.  Data are representative of five 
independent experiments. 
(C) Surface IL-21R expression on cultured CD8+ T cells was analyzed by flow 
cytometry at day 5 post-primary stimulation.  Data are representative of three 
independent experiments. 
(D) Purified splenic CD8+ T cells from IL-21-mKate reporter mice were cultured in 
the presence of the indicated cytokines for 4 days.  The cells were analyzed by 
flow cytometry without re-stimulation.  Representative of two experiments. 
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effectors.  Moreover, adoptive transfer of IL-21R-sufficient CD8+ T cells into Il21r-
/- mice, but not B6 mice, led to a significant increase in collagen concentration in 
lung extracts after bleomycin treatment.  Adoptive transfer of IL-21R-sufficient 
CD4+ T cells had a negligible effect on collagen deposition (Figure 3.12C).  
Restoration of fibrosis and fibroblast activation by IL-21R-sufficient CD8+ T cells 
in Il21r-/- mice treated with bleomycin was also confirmed histologically by 
immunohistochemical staining for collagen and α-smAc (Figure 3.12D).  Thus, IL-
21 responsive CD8+ T cells are necessary and sufficient for reconstituting the 
fibrotic phenotype following lung injury in Il21r-/- mice. 
 The ability of wt CD8+ T cells, but not wt CD4+ T cells to restore fibrosis in 
Il21r-/- mice was somewhat surprising given that Th2 cells have been closely 
associated with fibrosis.  It seemed likely that the cytotoxic capacity of CD8+ T 
cells could render them more pathogenic than CD4+ T cells in vivo.  I 
hypothesized that increased cytotoxicity of Th2 cells would drive fibrosis.  T cells 
from mice deficient in the death receptor express higher levels of FasL on their 
surface (Chu et al., 1995), which could heighten cytotoxic potential.  FasL can be 
cleaved by matrix metalloproteinases.  The membrane bound form is pro-
apoptotic and pro-inflammatory and the soluble form can be inhibitory (Hohlbaum 
et al., 2000).  Our lab generated a transgenic mouse with a deletion in the FasL 
cleavage site (ΔCS), which leads to increased pro-inflammatory function of FasL 
(Bossaller et al., 2013).  If crossed to the DO11 Tg, when injected, these cells 
would theoretically respond preferentially in the lung of a mouse expressing ova 
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Figure 3.12. IL-21R on CD8+ T cells is required for optimal IL-13 production 
and collagen deposition.   
 
(A) 106 purified splenic CD4+ or CD8+ T cells from naïve B6 mice were injected 
i.v. into B6 and Il21r-/- mice at day -1.  At day 0, mice were treated i.t. with PBS 
or bleo.  LDLN cell suspensions from PBS and bleo-treated mice were collected 
at day 14 and stimulated with anti-CD3.  Cell supernatants were harvested at 24 
hours and assayed for IL-13. 
(B) Cells were prepared and stimulated as above and culture fluids were assayed 
for IFN-γ . 
(C) Lungs were harvested at day 14 and lung extracts were quantitated for 
collagen concentration by Sircol assay. 
(D) Lung sections obtained from day 14 were stained for α-smooth muscle actin 
to detect fibroblast activation Magnification = 20X.   
Data are representative of two independent experiments (PBS!B6, n=5; PBS! 
Il21r-/-, n=4; Bleomycin!B6, n=9; Bleomycin! Il21r-/- , n=8; Bleomycin!B6 + wt CD4, 
n=5; Bleomycin!B6 + wt CD8, n=8; Bleomycin!Il21r-/- + wt CD4, n=5; 
Bleomycin!Il21r-/- + wt CD8, n=9).  Bars represent means ± SEM. 
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in the lung.  To investigate the role of cytotoxicity in a system that was readily 
available in our lab, we made use of a double transgenic mouse line, which 
expresses TGO (membrane-bound OVA fusion protein) under the control of a 
lung-specific promoter in the presence of dox (CC10-TGO).  I injected CC10-
TGO mice (on dox) with Th2 cells differentiated in vitro with T cells from DO11, 
DO11-Faslpr, or DO11-FaslprxFasL ΔCS/ΔCS mice.  CC10-TGO mice injected with 
DO11-Faslpr, or DO11-FaslprxFasL ΔCS/ΔCS cells had increased collagen 
deposition in the lung as measured by blinded scoring Masson’s trichrome 
stained lung slides compared to mice that received DO11 cells with wt FasL 
(Figure 3.13A,C).  LDLN T cells from recipients of all three genotypes of T cells 
secreted IL-13 in response to anti-CD3, with no significant difference between 
groups (Figure 3.13B).  CC10-TGO mice had a higher frequency of DO11 cells in 
the lung compared to TGO only hosts (Figure 3.13D), and many produced IL-4 
after re-stimulation (Figure 3.13E). These preliminary experiments suggest that 
cytotoxicity may be an important component of Tc2-driven pathology.   
 
Discussion 
Fibrosis is a frequent outcome of chronic inflammation, but despite extensive 
investigation, the pathways responsible for the transition from inflammation to 
fibrosis remain incompletely understood.  Over-exuberant type 2 responses 
characterized by high levels of IL-4 and IL-13 are often linked to fibrogenesis, 
however, the initiating signals for such responses are not clear.  Through the 
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Figure 3.13. Increased cytotoxicity of CD4+ T cells may promote fibrosis.  
 
5x106 Th2 cells differentiated in vitro with T cells from DO11, DO11-Faslpr, or 
DO11-FaslprxFasL ΔCS/ΔCS mice were injected into CC10-TGO or TRE-TGO mice 
on dox.  At day 18, mice were sacrificed and lungs and LDLN were harvested.  
A-B show data from one experiment, C-E show data from a separate experiment. 
(A) Results of blinded scoring of lung sections stained with Masson’s trichrome. 
(B) LDLN cell suspensions were stimulated with anti-CD3.  Cell supernatants 
were harvested at 24 hours and assayed for IL-13. 
(C) Representative lung sections stained with Masson’s trichrome. 
(D) Frequency of DO11 T cells in LDLN of CC10-TGO or TRE-TGO mice tallied 
from flow cytometry plots. 
(E) Intracellular cytokine staining of ex vivo re-stimulated DO11 T cells LDLN of 
CC10-TGO or TRE-TGO mice. 
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analysis of IL-21R-deficient mice, we have now shown that lung fibrosis and 
optimal IL-13 production in response to bleomycin lung injury is dependent on IL-
21R signaling, thus identifying IL-21 as a potential therapeutic target for IPF and 
SSc.  Previous work showed that bleomycin induced lung fibrosis is ameliorated 
by neutralization of IL-13 or depletion of IL-13 responsive cells (Belperio et al., 
2002; Jakubzick et al., 2003; Rosada et al., 2010).  In accordance with these 
studies, we found that IL-21R deficiency and protection from fibrosis was 
associated with a striking reduction in IL-13 production by lung T cells ex vivo.  
Intriguingly, protection from fibrosis in Il21r-/- mice was not associated with a 
significant reduction of inflammation.  Il21r-/- mice have also been shown to 
develop less severe fibrosis in a schistosomiasis-associated liver fibrosis model, 
however, this effect was attributed to IL-21 induction of Th2 cells and the 
promotion of increased macrophage sensitivity to Th2 cytokines such as IL-4 and 
IL-13 (Pesce et al., 2006).  A recent study identified IL-21 as the link between G-
CSF-mobilized hematopoietic stem cells and CD4+ T cell-independent 
sclerodermatous graft-versus-host disease (Hill et al., 2010).  The data presented 
here further question whether CD4+ T cells are sole mediators of fibrosis.  We 
show that in the bleomycin model, IL-13 secreting CD8+ T cells, or Tc2 cells, and 
not Th2 cells, were profoundly impacted by IL-21R deficiency.  This finding was 
unexpected since CD4+ T cells have been charged with driving fibrosis through 
the production of both IL-17A (Oh et al., 2011; Wilson et al., 2010) and IL-13 
(Belperio et al., 2002; Fichtner-Feigl et al., 2006).  
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IL-21 has been implicated in the induction and amplification of both Th2 
(Frohlich et al., 2007; Pesce et al., 2006; Wurster et al., 2002) and Th17 cells 
(Korn et al., 2007), however, in the case of Th17 cells the data have been less 
clear-cut (Coquet et al., 2008; Sonderegger et al., 2008).  In our experiments, IL-
17A production was not affected by loss of IL-21R signaling.  Thus, our work 
confirms the tissue- and context-specific role of IL-21 in Th17 differentiation. Two 
studies have shown an unexpected role for IL-17A derived from Th17 cells in the 
bleomycin model of pulmonary fibrosis (Oh et al., 2011; Wilson et al., 2010).  Oh 
et al. injected IL-17A neutralizing antibodies at both early and later time points 
and found that while IL-17A was required early in the response, IL-17A blockade 
after day 10 did not ameliorate lung fibrosis (Oh et al., 2011).  Wilson et al. also 
found that IL-17A was required for bleomycin induced lung fibrosis at an early 
time point (day 7), when IL-13 was dispensable (Wilson et al., 2010).  Other 
studies have implicated IL-13 in pulmonary fibrosis at more commonly examined 
time points such as days 21-28 (Jakubzick et al., 2003; Rosada et al., 2010), as 
well as earlier time points (Belperio et al., 2002). In this paper we show that 
despite the presence of Th17 cells in the lung and LDLN, as well as comparable 
IL-17A production by LDLN T cells, Il21r-/- mice were protected from bleomycin-
induced fibrosis.  These studies, taken together with the data presented here, 
suggest that IL-17A has an important role in the initial stages of fibrosis, 
however, IL-21-dependent IL-13 production is required for persistent fibrosis 
through day 21.  Accordingly, Th17 cells could be an important source of the IL-
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21 that skews CD8+ T cells toward the production of IL-13 (Tc2), in addition to 
the IL-21 secreting cells we found in naïve mice (Fig. 4A).  Interestingly, such IL-
21-dependent Th2 and Tc2 cells could suppress the further development of Th17 
cells through the production of IL-4 (Cooney et al., 2011), thus reinforcing a type 
2-biased environment.  These data may explain why increased levels of IL-17A 
are detected in SSc patient sera at early, but not later stages, of disease 
(Radstake et al., 2009) and support a biphasic immunopathology driving fibrosis. 
 Our results further showed that CD8+ T cells, namely Tc2 cells, were most 
profoundly impacted by IL-21R deficiency.  Previously, the physiological 
significance of Tc2 cells in vivo had been controversial since most functional 
studies of Tc2 cells used in vitro-skewed cells for adoptive transfer.  In vitro-
differentiated Tc2 cells are less potent effectors in pulmonary viral clearance and 
tumor rejection when compared to Tc1 cells (Cerwenka et al., 1999; Helmich and 
Dutton, 2001).  However, in murine asthma, Tc2 cells develop and increase both 
airway inflammation and hyper-responsiveness (Miyahara et al., 2004).  We now 
show that IL-21-dependent Tc2 cells are required for lung fibrosis after sterile 
lung injury, as both IL-13 production and fibrosis were restored by transferring IL-
21R+/+ CD8+ T cells into Il21r-/- mice treated with bleomycin.  This result points 
to a novel role for IL-21 in Tc2 differentiation.  Studies by other investigators have 
shown that Tc2 differentiation can be achieved in vitro using a combination of IL-
2 and IL-4 (Croft et al., 1994; Sad et al., 1995).  Here we have shown that IL-21, 
in conjunction with IL-4, can replace the need for exogenous IL-2 in Tc2 
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differentiation, a new and unanticipated role for IL-21 in CD8+ T cell responses.  
However, the role of IL-21 was not neutral, since, CD25 blockade enhanced Tc2 
differentiation in response to IL-21/IL-4, which again pointed to a specific role for 
IL-21 during fibrogenesis that cannot be replaced by IL-2. 
Interestingly, our in vitro experiments also showed that upon activation, 
CD8+ T cells secrete IL-21 at low-levels to amplify IFN-γ production through an 
autocrine process.  Higher levels of IL-21 (detectable by ELISA) were secreted 
only in response to both IL-4 and IL-21, but not to either alone.  Furthermore, a 
population of CD8+ T cells recruited to the lung after instillation of bleomycin or 
IL-21 produced IL-13.  Our finding that CD8+ T cells produce IL-21 in vivo was 
unexpected, and could reflect a phenotype that is specific to the sterile type 2 
environment and not mounted during viral or parasitic infections.  To the best of 
our knowledge, this is the first report of IL-21 production by CD8+ T cells with 
relevance to a disease model.  IL-21 message was detected in T-bet and 
Eomesodermin double-knockout Tc17 cells, however, IL-21 was not detected in 
Tc17 cultures by ELISA (Ciric et al., 2009).  We now show that CD8+ T cell 
production of IL-21 is induced in the type 2 environment, and that 
autocrine/paracrine IL-21 production promotes Tc2 responses.  Interestingly, 
fibroblasts in the gut express IL-21R and upregulate matrix metalloproteinases in 
response to IL-21 (Monteleone et al., 2006), raising the possibility that CD8+ T 
cell-derived IL-21 could act directly on fibroblasts. Moreover, IL-21 production by 
Tc2 cells could further reinforce a type II immune response due to the robust 
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effects of IL-21 on CD4+ T cells and innate immune effectors (Rochman et al., 
2009; Wan et al., 2013).  Strikingly, IL-21 instillation into the lungs of mice in the 
absence of other injurious stimuli led to fibrosis in addition to the development of 
both IL-13 and IL-21 producing CD8+ T cells.  Thus, the foregoing data show that 
IL-21 is both necessary and sufficient for pulmonary fibrosis.  
 In studying the differentiation of Tc2 cells, we found that TGF-β, a cytokine 
abundantly expressed in fibrotic tissues, specifically inhibited Tc2 differentiation.  
The finding that TGF-β decreased IL-21R expression on CD8+ T cells when 
combined with IL-4 was surprising due to the pro-fibrotic roles of both cytokines.  
However, this could reflect a “brake” on fibrogenesis by decreasing positive 
feedback through the IL-21R.  It should be noted that bleomycin-induced lung 
fibrosis is a self-limiting disease after single intratracheal instillations, and a TGF-
β-dependent feedback mechanism may be responsible for the spontaneous 
resolution of fibrosis.  TGF-β is also produced by macrophages (Song et al., 
2000), including alternatively activated macrophages, which are known to 
accumulate in the fibrotic lung (Gibbons et al., 2011; Pechkovsky et al., 2010). 
The capacity of macrophage-derived TGF-β to suppress Tc2 differentiation might 
explain why macrophage depletion after fibrosis is established was found to 
exacerbate collagen deposition (Duffield et al., 2005).  Additionally, the decrease 
in the expression of the IL-21R in response to TGF-β could be a mechanism by 
which Treg suppression of Tc2 cells is promoted.  Since IL-21 impairs Treg 
function (Attridge et al., 2012; Petrelli et al., 2011; Schmitz et al., 2013), Treg-
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derived TGF-β could thereby limit an IL-21R/IL-21 positive feedback loop, thus 
ensuring the potency of nearby Tregs by dampening local IL-21 production.  As 
IPF has certain features of autoimmunity such as clonal T cell expansion and 
autoantibodies (Feghali-Bostwick et al., 2007), Treg robustness could impact 
disease progression.  
In addition to a role for IL-21 in Tc2 skewing, we found that IL-21R 
signaling was required for optimal CD8+ T cell proliferation/recruitment.  Both the 
frequency and total number of CD8+ T cells were reduced in Il21r-/- mice during 
fibrogenesis compared to wild type controls.  The frequency and number of CD4+ 
T cells was affected to a lesser extent.  This data is consistent with a significant 
body of work characterizing mitogenic effects of IL-21 on CD8+ T cells.  
Furthermore, IL-21 is critical for controlling chronic viral infection, as it is a 
component of CD4+ T cells help to CD8+ T cells (Elsaesser et al., 2009; Yi et al., 
2009), and is also critical for production of antibody (Ozaki et al., 2002).  In the 
NOD model of diabetes, lack of IL-21R signaling also decreases CD8+ T cells 
and attenuates disease, however, in the NOD system, it has been reported that 
IL-21R+ CD4+ T cells and dendritic cells recruit cytotoxic CD8+ T cells into 
pancreatic islets (Van Belle et al., 2012).  However, we found that direct 
engagement of IL-21R on CD8+ T cells was required for fibrosis and optimal IL-
13 production during lung fibrogenesis.  Since fibrotic disease is a Th2/Tc2 
driven response, rather than the Th1/Tc1-driven NOD disease, our results could 
point to a requirement for IL-21R for a robust CD8+ T cell effector activity that is 
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specific to the type 2 environment caused by sterile fibrotic lung injury.  Whether 
our findings could be extended to other sterile injury models of fibrosis such as 
silica, or an infection model such as hypersensitivity pneumonitis remains to be 
determined.  
CD8+ T cells have been positively correlated with disease severity in 
patients with lung fibrosis (Atamas et al., 1999) and CD8+ T cell activation is 
increased in early, diffuse SSc (Radstake et al., 2009).  We now establish a role 
for CD8+ T cells among the repair/fibrosis class of effectors during sterile 
inflammation.  Importantly, a number of studies have linked Tc2 cells to fibrosis in 
human patients.  CD8+ T cells from systemic sclerosis patients secrete copious 
IL-13 and can activate fibroblasts in an IL-13 and STAT-6-dependent manner 
(Fuschiotti et al., 2013).  Additionally, in the peripheral blood of systemic 
sclerosis patients, a higher frequency of CD8+ T cells produces IL-13 than CD4+ 
T cells (Fuschiotti et al., 2013; Fuschiotti et al., 2009).  It has also been reported 
that the frequency of Tc2 cells in the lungs of IPF patients is correlated with 
disease severity and shortness of breath (Atamas et al., 1999), and CD8+ T cells 
are as, if not more, abundant than CD4+ T cells in the lungs of IPF patients 
(Daniil et al., 2005; Kradin et al., 1986; Papiris et al., 2005).  These studies, taken 
together with the current report, challenge the predominant CD4+ T cell-centric 
view of fibrosis.  Our data clearly point to an IL-21/IL-13 axis during fibrogenesis, 
requiring CD8+ T cells as effectors on both sides of this axis.  Overall, these 
results have important implications for the rational design of IL-21 targeted 
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therapies that could be used to treat fibrosis resulting from conditions such as 
SSc, IPF, or chronic inflammation. 
 
 
Experimental Procedures 
Mouse Strains 
BALB/c and C57BL/6 mice were purchased from the Jackson Laboratory.  IL-
21R knockout mice originally made by Warren Leonard (Ozaki et al., 2002) were 
provided by Oliver Dienz (University of Vermont) and IL-21 knockout mice were 
obtained from Lexicon- Mutant Mouse Regional Resource Centers and 
generously provided by Dr. S. Swain (University of Massachusetts Medical 
School).  All mouse experiments were approved by the Institutional Animal Care 
and Use Committee of the University of Massachusetts Medical School. 
  
Lung treatments 
12-16 week old mice were anesthetized by isoflurane inhalation.  50µl of sterile 
bleomycin sulfate (Sigma, 0.05U/mouse (low dose) or 0.15U/mouse (high dose) 
dissolved in sterile PBS), recombinant mouse IL-21 (R&D Systems, 1µg/mouse 
dissolved in sterile PBS), or PBS were instilled into the lungs of mice by 
oropharyngeal aspiration (Walters and Kleeberger, 2008).  For experiments 
where mice of different genotypes were compared, the mice were age-matched 
within two weeks difference in date of birth. 
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Lung and lymph node tissue harvesting 
Mice were sacrificed by cervical dislocation and immediate removal of the 
diaphragm. Lungs were perfused with PBS through the right ventricle to remove 
blood. Bronchoalveolar lavage fluid (BALF) was collected with three flushes of a 
single aliquot of 0.5ml PBS.  Lung draining lymph nodes were dissected and 
dissociated in Hank’s buffered saline solution (HBSS) using frosted glass slides.  
The right bronchus was sutured and the right and postcaval lobes were removed 
and placed in HBSS, minced, and forced through a 100µm nylon mesh filter to 
generate a single-cell suspension. The left lobe was inflated with 10% neutral 
buffered formalin, the left bronchus was sutured, and the left lobe was then 
removed and submerged in 10% buffered formalin at room temperature until 
processed for paraffin embedding (>24 hours). 
 
Collagen Measurement 
Where the left lung lobe was not used for histology, the entire lobe was minced 
into fine pieces and placed in 2 ml of a solution of acetic acid (Sigma, 0.5M) and 
pepsin.  After 48 hours, the solution was spun at 4C for 20 minutes, and these 
lung extracts were frozen until collagen concentration assay.  Sircol (Biocolor, 
Belfast, UK) or Sirius Red Total Collagen Detection kit (Chondrex) were used 
according to the manufacturers instructions with similar results. 
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Histopathology and immunohistochemistry 
Formalin fixed, paraffin embedded lung tissue was sectioned into 5 µm sections 
and stained by hematoxylin and eosin or Masson’s trichrome stain.  
Immunohistochemistry for α-smooth muscle actin (Santa Cruz Biotechnology, 
clone 1A4, 1:500 dilution) was performed without antigen retrieval, goat anti-
mouse IgG2a-HRP (Santa Cruz Biotechnology, 1:500 dilution) was used as a 
secondary antibody, with diaminobenzene (DAB; Vector Laboratories) as a 
substrate.  Mayer’s hematoxylin was used as a counterstain for 
immunohistochemistry. 
 
Flow cytometry 
Single cell suspensions were surface or intracellular stained with combinations 
the following antibodies: IL-21R-biotin, CD3-PE-Cy7, -biotin (clone 145-2C11), 
CD4-efluor450, -APC (clone RM4-5), CD8-FITC, -APC, -PE-Cy7 (clone 53-6.7), 
CD25-PerCP-Cy5.5 (clone PC61.5), CD69-efluor450, - PerCP-Cy5.5, IL-21-APC 
(cloneFFA21), IL-13-PE (clone eBio13A), IL-17A-PerCP-Cy5.5 (clone eBio17B7), 
Foxp3-PE (clone FJK-16s) all from eBioscience.  Strepavidin-PerCP was from 
BD Biosciences. 
For Foxp3 staining, cells were fixed and permeabilized using the Foxp3 
Transcription Factor staining buffer kit (eBioscience) according to the 
manufacturers instructions.  For intracellular cytokine staining, single-cell 
suspensions were stimulated ex-vivo with plate-bound anti-CD3 (BioLegend, 5 
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µg/ml) or PMA (Sigma, 100ng/ml) plus ionomycin (Sigma, 1µg/ml) in complete 
RPMI for 2 hours at 37°C.  GolgiStop (BD Biosciences, 1:100) was added and 
cultures were incubated for an additional 2-3 hours at 37°C. 
 
Cytokine measurements 
Lung draining lymph node single-cell suspensions (200,000-400,000 cells/well) 
were seeded onto anti-CD3 (BioLegend; 5µg/ml) coated plates in RPMI.  
Supernatants were collected at 24 hours and analyzed by ELISA for IL-13 (BD 
Biosciences), IL-21 (eBioscience), IFN-γ (BD Biosciences), and IL-17A 
(eBioscience). 
 
In vitro T cell differentiation 
CD8+ T cells were purified from spleen cell suspensions by positive selection (BD 
iMag CD8α beads).  Cells were stimulated with plate bound anti-CD3 (2 µg/ml) 
and soluble anti-CD28 (BioLegend, 2 µg/ml) with or without recombinant mouse 
IL-4 (BD Biosciences, 10 ng/ml), recombinant human IL-2 (BD Biosciences, 50 
ng/ml), recombinant mouse IL-21 (R&D Systems, 50ng/ml), or recombinant 
human TGF-β (Peprotech, 5ng/ml).  Anti-CD25 antibody was purified from PC61 
hybridoma supernatant (a generous gift from Dr. M. Shlomchik, University of 
Pittsburgh) and used at a concentration of 20 µg/ml.  Cells were split on day 2 
and then as needed.  On day 4 or 5, T cells were re-stimulated with anti-CD3 for 
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intracellular cytokine staining or re-stimulated to harvest supernatants for ELISA 
after 24 hours. 
 
Statistical methods 
Data analysis was performed using Prism (GraphPad) software.  p values were 
calculated using unpaired two-tailed Student’s t test.  In all figures, ns (not 
significant) denotes a p>0.05, *, p≤0.05, **,p≤0.01, ***,p≤0.001.  Error bars 
represent standard error of the mean (SEM). 
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Chapter IV: Discussion 
An initial goal of the Ii-TGO model of SLE was to induce disease with activated 
DO11 T cells, and then mimic lupus flares by turning TGO expression on and off 
to study the biology of B cells during simulated “flares.”  The ability to turn TGO 
on and off would theoretically allow for monitoring of the kinetics and magnitude 
of the ANA response, which may provide evidence for whether memory 
autoreactive B cells are involved in flares.  A previous graduate student, Karen 
Lee, showed that ANA+ Ii-TGO mice 6 weeks post DO11 Th2 adoptive transfer, 
withdrawal of dox led to a decrease in ANA titers.  This suggests that OVA-
specific effector cells, most likely DO11 Th2, maintained autoreactive B cell 
production of autoantibodies through cognate interactions.  This result is 
somewhat counterintuitive.  Using a traditional view of antibody responses, ANA-
producing B cells should have eventually become plasma cells and stopped 
requiring T cell help.  This result points to at least two possibilities: (1) 
autoreactive antibody secreting cells do not become true plasma cells and 
require T cell help for survival and/or (2) DO11 Th2 drive a differentiation 
pathway that is halfway between anergic and plasma cell and these cells still 
have a shorter half life than a non-autoreactive cell.  That is, DO11 cells persist 
when and antigen persists, and when DO11 cells persist, they can provide help 
to new anergic cells that develop into short-lived plasmablasts.  Short-lived 
plasmablasts such as these have been identified in anti-RF B cell transgenic 
mice on an MRL/lpr background (William et al., 2005), where they participate in 
113
  
an anti-RF response.  The dependence on TGO expression, which I interpret as 
dependence on DO11 cell persistence, exhibited in Th2!Ii-TGO lupus like 
disease could be specific to early stages of disease.  It is likely that as disease 
progressed, epitope spreading would occur, and autoreactive T cells specific for 
true auto-Ags could engage in cognate interactions with autoreactive B cells, 
thus precluding a requirement for DO11 T cells.  In this scenario, we would 
expect that an enduring break in B cell tolerance had occurred.  I attempted to 
address this question by generating mice that expressed TGO on half of their B 
cells, and did not express TGO on the other half in order to compare antibody 
production by each population following DO11 Th2 adoptive transfer.  I 
generated BM chimeras that were a 50/50 mix of Ii-TGO BM and C.B-17 BM.  
C.B-17 cells provide a source of normal, non-TGO expressing B cells, but also 
express Ighb, allowing for detection of antibody secreted by these cells using 
anti-allotype secondary reagents.  Curiously, less than 10% of B cells detected in 
reconstituted Ii-TGO/C.B-17 mixed BM chimeras expressed IgM[b] on their 
surface, suggesting that C.B-17 B cells survived poorly or that C.B-17 BM 
engrafted poorly.  However, this experiment could be difficult to interpret given 
that nonspecific T cell help could promote autoantibody production by C.B-17 B 
cells, especially in the context of inflammation. 
 The nature of Ii-TGO B cell/DO11 T cell interactions is currently unclear.  
DO11 T cells account for less than 1% of CD4+ T cells in the spleen several 
weeks or months after adoptive transfer, however, as described above, TGO 
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expression must be maintained for ANA titers to remain high.  To definitively 
show whether productive Ii-TGO B cell/DO11 T cell interactions occur, Ii-TGO B 
cells and CFSE-labeled DO11 T cells would need to be transferred into an MHC-
II-deficient host do determine whether T cell divisions are B cell-dependent.  
Whether Ii-TGO B cell/DO11 T cell interactions are sufficient for ANA production 
is presumed, but also unclear, and could be addressed using a long-term version 
of a similar experiment. 
The low frequency of adoptively transferred DO11 cells raises several 
questions about their fate.  Autoantibody responses can occur in germinal 
centers or at extrafollicular sites, and a determination of whether DO11 Th2 
become Tfh, Tefh, or localize with B cells in lymph nodes and spleen is important 
in the context of T-B interactions in lupus.  Tfh development and participation in 
germinal centers requires cognate and ICOS/ICOS ligand interactions with B 
cells (Tangye et al., 2013).   As discussed above, nonspecific T cell help can 
enhance autoantibody production.  However, this scenario may not be optimal or 
even likely to occur in an autoimmune individual; it is possible that Ag-specific T-
B interactions would outcompete nonspecific interactions, especially during early 
phases of disease.  
 
A variety of genetic and environmental factors are thought to lead to SLE 
(Choi et al., 2012).  Crossing an autoreactive BCR Tg mouse line to an 
autoimmune prone strain can promote evasion of B cell tolerance by autoreactive 
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B cells (Mandik-Nayak et al., 1999; Santulli-Marotto et al., 2001; Wang and 
Shlomchik, 1999).  It is therefore likely that the barriers to ANA production that 
we find in the Ii-TGO model would be less.  For example, I would predict that on 
an lpr or gld background, Ii-TGO B cells would become spontaneously activated 
by immune complexes and could then activate naïve DO11 T cells in a dox-
dependent manner.  A more sophisticated version of this experiment would utilize 
mixed bone marrow chimeras, with half of the bone marrow being Ii-TGO x Ighb, 
and the other half being BALB/c-lpr-gld (to prevent FasL-mediated graft versus-
host-disease or susceptibility to Fas-mediated death) or normal BALB/c.   This 
would allow for assessment of ANA production by Ii-TGO B cells in an 
autoimmune environment, without requiring Ii-TGO B cells to be genetically 
autoimmune prone. 
LNSCs have a clear role in peripheral tolerance through both autoreactive 
CD8 T cell deletion and suppression of CD4 and CD8 T cell proliferation 
(Fletcher et al., 2010; Fletcher et al., 2011; Khan et al., 2011; Lukacs-Kornek et 
al., 2011; Siegert et al., 2011).  Suppression of T cell proliferation by LNSCs is 
mediated by iNOS (Lukacs-Kornek et al., 2011), which may also induce Tregs 
(Niedbala et al., 2007).  A role for iNOS in regulating Treg trafficking has not 
been shown, however LNSCs express other factors, such as IL-7, which could 
impact Treg phenotype.  Literature on stroma and Tregs is extremely limited – 
and this potential interaction may have been overlooked due to the relatively low 
level of MHC-II on LNSCs.  However, MHC-II is increased on LNSCs during 
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inflammation, and Tregs may respond to low levels of MHC-II due to higher 
affinity for self-peptide.  It would be quite interesting to know whether LNSCs 
from an inflamed environment (e.g. an autoimmune mouse lymph node) would 
interact with Tregs differently, but this would likely be dependent on the 
mediators of stromal/Treg interactions.  The first step in identifying the 
molecule(s) responsible for CD62L upregulation on Tregs would be to determine 
whether it is a soluble factor or a membrane-bound ligand.  In addition to IL-7, 
PD-L1 could be a likely target, since it is both expressed by LNSC (Reynoso et 
al., 2009) and can promote Treg induction and influence function (Francisco et 
al., 2009). 
The circumstantial evidence for activation and preferential lymph node 
homing in the prevention of ANA production in this system in clear, however, the 
true functional capacity of CD62L+ Tregs has not been shown in our model.  
These cells are very protective in graft-versus-host disease responses, and are 
feasible to adoptively transfer (Ermann et al., 2005; Fu et al., 2004; Szanya et al., 
2002).  The suppressive function of CD62L+ DO11 Tregs on a per-cell basis 
could be tested in vitro, since some or all of these cells could express other 
molecules that make them more potent suppressors than CD62L- Tregs.  To 
determine whether CD62L+ Tregs exhibit enhanced homing to sites of 
autoreactive B cell activation, CD62L+ Tregs from DO11 x Ii-TGO or wild type 
mice could be transferred into an autoimmune model with a similar genetic 
background such as BALB/c-lpr.  I hypothesize that localization in lymph nodes, 
117
  
rather than increased suppressive capacity, would attenuate autoreactive B cell 
activity. 
While it is presumably conventional Tregs that prevent autoantibody 
production in Ii-TGO chimeras with host TGO expression, other regulatory 
populations could be responsible.  Tfh cells promote B cell antibody production in 
germinal centers through a variety of membrane-bound and soluble factors 
including CD40/CD40L interactions and IL-21 (Tellier and Nutt, 2013).  Tfh that 
express Foxp3 have been described, and may have a regulatory role in germinal 
centers (Chung et al., 2011; Linterman et al., 2011).  Autoimmune responses that 
lead to the production of autoantibodies can occur in extrafollicular foci rather 
than germinal centers (Odegard et al., 2008).  Whether Tefh can also express 
Foxp3, and whether the self-Ag/rAPC-dependent regulatory population that may 
be responsible for attenuated B cell activation and ANAs in Ii-TGO!Ii-TGO 
chimeras is a regulatory Tfh/Tefh rather than a conventional Treg remains to be 
determined. 
In the Ii-TGO system, we used Th2 cells to drive SLE-like disease, 
however, SLE has been associated with type I IFN and IFN-γ, and diseases such 
as SSc have been associated with deregulated Th2 responses.  While we were 
developing a model of T cell-driven fibrosis, data on the role of Th17 cells in 
fibrosis shifted the Th2-bias paradigm.  I hypothesized that Th17 and Th2 
responses could be linked in fibrosis, and that IL-21 overproduction could lead to 
deregulated activity of both.  We tested this hypothesis using the bleomycin 
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model of lung injury, which causes inflammation followed by fibrosis. We 
expected that the number of inflammatory cells infiltrating the lung and lung 
draining lymph nodes after bleomycin treatment would be dramatically reduced in 
IL-21R-deficient mice.  Although overall cell numbers were similar between B6 
and Il21r-/- mice, the ratio of CD4+/CD8+ T cells was significantly increased in 
Il21r-/- mice.  The fact that IL-21R-deficiency had a greater impact on CD8+ T cell 
numbers suggests that IL-21 actively promotes CD8+ T cell responses, as is 
suggested by the increased number of CD8+ memory T cells in IL-21-
overexpressing mice (Allard et al., 2007).  Il21r-/- mice were also completely 
protected from fibrosis, and this was accompanied by decreased IL-13 
production by LDLN T cells re-stimulated ex vivo.  Unexpectedly, intracellular 
cytokine staining revealed a decreased frequency of IL-13+ CD8+ T cells, rather 
than a decrease in IL-13+ CD4+ T cells.  Data from patients with SSc 
demonstrates that type 2-skewed CD8+ T cells are increased in SSc patients, 
secrete IL-13 at levels that can activate fibroblasts (Fuschiotti et al., 2013; 
Fuschiotti et al., 2009), and are associated with lung function decline (Atamas et 
al., 1999).  We have begun staining human lung tissue from health individuals, 
SSc patients, and IPF patients.  We have found IL-13+ cells in the lungs of 
patients with SSc, but not healthy controls.  It is of interest to determine whether 
any of the IL-13+ cells are CD8+ T cells, and whether they co-express IL-21. 
Our data showed an unexpected autocrine role for IL-21 in promoting Tc2 
differentiation.  In response to the combination of IL-21 and IL-4, CD8+ T cells 
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secreted IL-21 and IL-13.  IL-21 deficient cells did not make IL-13, suggesting 
that autocrine/paracrine feedback could be required for proper Tc221 
differentiation and function.  This idea could be confirmed by treated CD8+ T 
cells under Tc221 conditions with increasing concentrations of IL-21.  We could 
next ask whether Tc221 cells become IL-21 independent in later stages of 
differentiation.  Transfer of Tc221 cells, but not conventional Tc2 cells, caused 
lung fibrosis.  While this could be a direct effect of IL-21, which can drive fibrosis, 
it could also be indicative of increased survival of Tc221 cells due to their ability to 
secrete copious amounts of IL-21.  These experiments should be repeated using 
a congenic marker such at Thy1.1, so that adoptively transferred cells can be 
detected by flow cytometry, and the numbers of conventional Tc2 versus Tc221 
cells can be compared.  It will also be important to assess the stability of both 
lineages by production of IL-13 compared to other T lineage cytokines. 
Our data show that IL-21R sufficient CD8+ T cells are required for 
bleomycin-induced fibrosis, but IL-21R-sufficient CD4+ T cells are dispensable.  
This result was surprising, since Th2 cells are classically associated with fibrosis.  
Apoptosis is involved in the pathogenesis of IPF and the bleomycin model 
(Thannickal and Horowitz, 2006) and perforin-deficient mice develop attenuated 
pulmonary fibrosis (Miyazaki et al., 2004).   Taking the role of apoptosis into 
consideration, it is possible that while CD4+ T cells may secrete pro-fibrotic 
cytokines, the low cytotoxic potential of Th2 cells makes them ineffective.  In 
CC10-TGO hosts injected with activated DO11 Th2, lpr cells caused more 
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collagen deposition, which could be a result of increased FasL on the surface of 
DO11 lpr cells that causes cell death and promotes fibrogenesis.  One future 
direction could be to skew Th1, Th2, and Th17 DO11 lpr cells to compare their 
fibrogenic potential in CC10-TGO hosts.  IFN-γ (Fielding et al., 2014), IL-13 
(Wynn, 2011), and IL-17A (Oh et al., 2011; Wilson et al., 2010) have all been 
associated with fibrosis, and the role T cell mediated cytotoxicity in this context 
remains unclear.   
CD8-mediated cytotoxicity would presumably involve peptide:MHC-I 
recognition.  It is unknown whether T cells recognize self-Ag in the bleomycin 
model, or whether non-specific activation occurs.  We are in the process of 
answering this question by reconstituting Rag1-/- hosts with wild type CD8+ T 
cells or OT-I-Rag1-/- T cells, with or without CD4+ T cells, then treating with 
bleomycin.  Adoptive transfer experiments showed that of OT-I Tc221 cells cause 
increased collagen deposition in the lungs of CC10-mOVA mice.  However, Tg-
negative littermates did not exhibit increased collagen in BAL fluid.  Data from 
this experiment suggests that Ag recognition by Tc2 is required for fibrosis.  
Because the OT-I Tc2 cells were transferred into a non-inflammatory 
environment, the requirement for Ag recognition could have been greater since 
there was no ongoing inflammation to activate CD8+ “bystanders.”  The extent of 
CD8+ T cell contribution to pulmonary fibrosis is obscure, but the novel pathway 
to type 2 effector CD8+ T cells described here may provide a foundation for future 
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studies using more definitive approaches such as conditional deletion of IL-21 or 
IL-21R. 
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